Wikiproyecto:Medicina/Cochrane/Revisiones Cochrane en es.Wikipedia/Brain, Nerves and Mind

Bienvenida

¿Cómo editar?

¿Cómo empezar?

Revisiones Cochrane en Wikipedia Español

Resúmenes en términos sencillos

[Biblioteca Cochrane|Biblioteca Cochrane]

¿Preguntas?

Brain, Nerves and Mind:
Revisiones que pueden ser consideradas para Wikipedia

Common Mental Disorders Group

01/11/2011 Pharmacological interventions for the treatment of anxiety disorders in chronic obstructive pulmonary disease PMID:22071851.0 https://doi.org/10.1002/14651858.CD008483.pub2

01/12/2011 Tiagabine in the maintenance treatment of bipolar disorder PMID:22161389.0 https://doi.org/10.1002/14651858.CD005173.pub3

01/12/2011 Mirtazapine versus other antidepressive agents for depression PMID:22161405.0 https://doi.org/10.1002/14651858.CD006528.pub2

01/12/2011 Second-generation antidepressants for seasonal affective disorder PMID:22161433.0 https://doi.org/10.1002/14651858.CD008591.pub2

01/12/2011 Oxcarbazepine for acute affective episodes in bipolar disorder PMID:22161387.0 https://doi.org/10.1002/14651858.CD004857.pub2

01/10/2012 Collaborative care for depression and anxiety problems PMID:23076925.0 https://doi.org/10.1002/14651858.CD006525.pub2

01/10/2012 Duloxetine versus other anti-depressive agents for depression PMID:23076926.0 https://doi.org/10.1002/14651858.CD006533.pub2

01/11/2012 Psychological therapies for pathological and problem gambling PMID:23152266.0 https://doi.org/10.1002/14651858.CD008937.pub2

01/11/2012 Interventions for preventing relapse and recurrence of a depressive disorder in children and adolescents PMID:23152246.0 https://doi.org/10.1002/14651858.CD007504.pub2

01/11/2020 Cognitive behavioural therapy for anxiety disorders in children and adolescents PMID:33196111.0 https://doi.org/10.1002/14651858.CD013162.pub2

01/09/2020 An overview of systematic reviews on mental health promotion, prevention, and treatment of common mental disorders for refugees, asylum seekers, and internally displaced persons PMID:32885850.0 https://doi.org/10.1002/14651858.CD013458.pub2

01/09/2020 Means restriction for the prevention of suicide on roads PMID:32966589.0 https://doi.org/10.1002/14651858.CD013738

01/09/2020 Psychological and social interventions for the prevention of mental disorders in people living in low- and middle-income countries affected by humanitarian crises PMID:32897548.0 https://doi.org/10.1002/14651858.CD012417.pub2

01/08/2020 Behavioural activation therapy for depression in adults with non-communicable diseases PMID:32841367.0 https://doi.org/10.1002/14651858.CD013461.pub2

01/07/2020 Interventions for the management of obesity in people with bipolar disorder PMID:32687629.0 https://doi.org/10.1002/14651858.CD013006.pub2

01/07/2020 Psychosocial interventions for conversion and dissociative disorders in adults PMID:32681745.0 https://doi.org/10.1002/14651858.CD005331.pub3

01/07/2020 Psychological therapies for women who experience intimate partner violence PMID:32608505.0 https://doi.org/10.1002/14651858.CD013017.pub2

01/07/2020 Behavioural activation therapy for depression in adults PMID:32628293.0 https://doi.org/10.1002/14651858.CD013305.pub2

01/02/2020 Means restriction for the prevention of suicide by jumping PMID:32092795.0 https://doi.org/10.1002/14651858.CD013543

01/08/2019 Multiple session early psychological interventions for the prevention of post-traumatic stress disorder PMID:31425615.0 https://doi.org/10.1002/14651858.CD006869.pub3

01/06/2019 Antidepressants plus benzodiazepines for adults with major depression PMID:31158298.0 https://doi.org/10.1002/14651858.CD001026.pub2

01/06/2019 Lithium for acute mania PMID:31152444.0 https://doi.org/10.1002/14651858.CD004048.pub4

01/06/2019 Melatonin and agomelatine for preventing seasonal affective disorder PMID:31206585.0 https://doi.org/10.1002/14651858.CD011271.pub3

01/05/2019 Family therapy approaches for anorexia nervosa PMID:31041816.0 https://doi.org/10.1002/14651858.CD004780.pub4

01/05/2019 Comparative effectiveness of continuation and maintenance treatments for persistent depressive disorder in adults PMID:31106850.0 https://doi.org/10.1002/14651858.CD012855.pub2

01/05/2019 Psychological therapies for preventing seasonal affective disorder PMID:31124141.0 https://doi.org/10.1002/14651858.CD011270.pub3 01/03/2019 Light therapy for preventing seasonal affective disorder PMID:30883670.0 https://doi.org/10.1002/14651858.CD011269.pub3

01/03/2019 Benzodiazepines versus placebo for panic disorder in adults PMID:30921478.0 https://doi.org/10.1002/14651858.CD010677.pub2

01/03/2019 Psychological therapies for the treatment of depression in chronic obstructive pulmonary disease PMID:30838649.0 https://doi.org/10.1002/14651858.CD012347.pub2

01/03/2019 Second-generation antidepressants for preventing seasonal affective disorder in adults PMID:30883669.0 https://doi.org/10.1002/14651858.CD011268.pub3

01/01/2019 Inpatient versus outpatient care, partial hospitalisation and waiting list for people with eating disorders PMID:30663033.0 https://doi.org/10.1002/14651858.CD010827.pub2

01/08/2018 Client feedback in psychological therapy for children and adolescents with mental health problems PMID:30124233.0 https://doi.org/10.1002/14651858.CD011729.pub2

01/08/2018 E-Health interventions for anxiety and depression in children and adolescents with long-term physical conditions PMID:30110718.0 https://doi.org/10.1002/14651858.CD012489.pub2

01/07/2018 Psychological therapies for the treatment of mental disorders in low- and middle-income countries affected by humanitarian crises PMID:29975811.0 https://doi.org/10.1002/14651858.CD011849.pub2

01/06/2018 Couple therapy for depression PMID:29882960.0 https://doi.org/10.1002/14651858.CD004188.pub3

01/05/2018 Psychological therapies for treatment-resistant depression in adults PMID:29761488.0 https://doi.org/10.1002/14651858.CD010558.pub2

01/05/2018 Antidepressants for insomnia in adults PMID:29761479.0 https://doi.org/10.1002/14651858.CD010753.pub2

01/04/2018 Antidepressants for preventing postnatal depression PMID:29669175.0 https://doi.org/10.1002/14651858.CD004363.pub3

01/04/2018 Antidepressants versus placebo for panic disorder in adults PMID:29620793.0 https://doi.org/10.1002/14651858.CD010676.pub2

01/01/2018 Antidepressants for depression in adults with HIV infection PMID:29355886.0 https://doi.org/10.1002/14651858.CD008525.pub3

01/07/2017 Vortioxetine for depression in adults PMID:28677828.0 https://doi.org/10.1002/14651858.CD011520.pub2

01/03/2017 Psychological therapies for the treatment of anxiety disorders in chronic obstructive pulmonary disease PMID:28322440.0 https://doi.org/10.1002/14651858.CD010673.pub2

01/09/2016 Continuation and maintenance treatments for depression in older people PMID:27609183.0 https://doi.org/10.1002/14651858.CD006727.pub3

01/09/2016 Antidepressants and benzodiazepines for panic disorder in adults PMID:27618521.0 https://doi.org/10.1002/14651858.CD011567.pub2

01/09/2016 Topiramate for acute affective episodes in bipolar disorder in adults PMID:27591453.0 https://doi.org/10.1002/14651858.CD003384.pub3

01/08/2016 Cognitive behavioural therapy (CBT), third-wave CBT and interpersonal therapy (IPT) based interventions for preventing depression in children and adolescents PMID:27501438.0 https://doi.org/10.1002/14651858.CD003380.pub4

01/07/2016 Routine use of patient reported outcome measures (PROMs) for improving treatment of common mental health disorders in adults PMID:27409972.0 https://doi.org/10.1002/14651858.CD011119.pub2

01/05/2016 Psychosocial interventions for self-harm in adults PMID:27168519.0 https://doi.org/10.1002/14651858.CD012189

01/04/2016 Psychological therapies for post-traumatic stress disorder and comorbid substance use disorder PMID:27040448.0 https://doi.org/10.1002/14651858.CD010204.pub2

01/04/2016 Psychological therapies for panic disorder with or without agoraphobia in adults: a network meta-analysis PMID:27071857.0 https://doi.org/10.1002/14651858.CD011004.pub2

01/03/2016 Therapist-supported Internet cognitive behavioural therapy for anxiety disorders in adults PMID:26968204.0 https://doi.org/10.1002/14651858.CD011565.pub2

01/09/2015 Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adults PMID:26415966.0 https://doi.org/10.1002/14651858.CD011611.pub2

01/09/2015 Ketamine and other glutamate receptor modulators for depression in adults PMID:26395901.0 https://doi.org/10.1002/14651858.CD011612.pub2

01/07/2015 Pharmacological interventions for self-harm in adults PMID:26147958.0 https://doi.org/10.1002/14651858.CD011777

01/07/2015 Pharmacological treatment for psychotic depression PMID:26225902.0 https://doi.org/10.1002/14651858.CD004044.pub4

01/07/2015 Individual psychological therapy in the outpatient treatment of adults with anorexia nervosa PMID:26212713.0 https://doi.org/10.1002/14651858.CD003909.pub2

01/05/2015 Augmentation of cognitive and behavioural therapies (CBT) with d-cycloserine for anxiety and related disorders PMID:25957940.0 https://doi.org/10.1002/14651858.CD007803.pub2

01/04/2015 Reiki for depression and anxiety PMID:25835541.0 https://doi.org/10.1002/14651858.CD006833.pub2

01/04/2015 Debriefing interventions for the prevention of psychological trauma in women following childbirth PMID:25858181.0 https://doi.org/10.1002/14651858.CD007194.pub2

01/02/2015 Morita therapy for anxiety disorders in adults PMID:25695214.0 https://doi.org/10.1002/14651858.CD008619.pub2

01/02/2015 Cognitive behavioural therapy for anxiety disorders in children and adolescents PMID:25692403.0 https://doi.org/10.1002/14651858.CD004690.pub4

01/02/2015 Dance movement therapy for depression PMID:25695871.0 https://doi.org/10.1002/14651858.CD009895.pub2

01/01/2015 Pharmacotherapy for anxiety and comorbid alcohol use disorders PMID:25601826.0 https://doi.org/10.1002/14651858.CD007505.pub2

01/09/2014 Azapirones versus placebo for panic disorder in adults PMID:25268297.0 https://doi.org/10.1002/14651858.CD010828.pub2

01/09/2014 Repetitive transcranial magnetic stimulation (rTMS) for panic disorder in adults PMID:25230088.0 https://doi.org/10.1002/14651858.CD009083.pub2

01/09/2014 Antidepressant treatment for postnatal depression PMID:25211400.0 https://doi.org/10.1002/14651858.CD002018.pub2

01/07/2014 Pharmacological interventions for preventing post-traumatic stress disorder (PTSD) PMID:25001071.0 https://doi.org/10.1002/14651858.CD006239.pub2

01/07/2014 Short-term psychodynamic psychotherapies for common mental disorders PMID:24984083.0 https://doi.org/10.1002/14651858.CD004687.pub4

01/04/2014 Paroxetine versus other anti-depressive agents for depression PMID:24696195.0 https://doi.org/10.1002/14651858.CD006531.pub2

01/09/2013 Media-delivered cognitive behavioural therapy and behavioural therapy (self-help) for anxiety disorders in adults PMID:24018460.0 https://doi.org/10.1002/14651858.CD005330.pub4

01/07/2013 Fluoxetine versus other types of pharmacotherapy for depression PMID:24353997.0 https://doi.org/10.1002/14651858.CD004185.pub3

01/06/2013 Tricyclic drugs for depression in children and adolescents PMID:23780719.0 https://doi.org/10.1002/14651858.CD002317.pub2

01/05/2013 Strategies for managing sexual dysfunction induced by antidepressant medication PMID:23728643.0 https://doi.org/10.1002/14651858.CD003382.pub3

01/07/2012 Citalopram versus other anti-depressive agents for depression PMID:22786497.0 https://doi.org/10.1002/14651858.CD006534.pub2

01/12/2012 Interventions to facilitate return to work in adults with adjustment disorders PMID:23235630.0 https://doi.org/10.1002/14651858.CD006389.pub2

01/09/2011 Counselling for mental health and psychosocial problems in primary care PMID:21901675.0 https://doi.org/10.1002/14651858.CD001025.pub3

01/12/2012 Tiagabine for acute affective episodes in bipolar disorder PMID:23235614.0 https://doi.org/10.1002/14651858.CD004694.pub3

01/12/2012 Psychological therapies for the treatment of post-traumatic stress disorder in children and adolescents PMID:23235632.0 https://doi.org/10.1002/14651858.CD006726.pub2

01/12/2012 Interventions for vaginismus PMID:23235583.0 https://doi.org/10.1002/14651858.CD001760.pub2

01/10/2013 'Third wave' cognitive and behavioural therapies versus other psychological therapies for depression PMID:24142844.0 https://doi.org/10.1002/14651858.CD008704.pub2

01/10/2013 Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder PMID:24132760.0 https://doi.org/10.1002/14651858.CD003196.pub2

01/10/2013 Behavioural therapies versus other psychological therapies for depression PMID:24129886.0 https://doi.org/10.1002/14651858.CD008696.pub2

01/10/2013 Enhanced care by generalists for functional somatic symptoms and disorders in primary care PMID:24142886.0 https://doi.org/10.1002/14651858.CD008142.pub2

01/11/2013 Pharmacotherapy for trichotillomania PMID:24214100.0 https://doi.org/10.1002/14651858.CD007662.pub2

01/12/2013 Agomelatine versus other antidepressive agents for major depression PMID:24343836.0 https://doi.org/10.1002/14651858.CD008851.pub2

01/12/2013 Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults PMID:24338345.0 https://doi.org/10.1002/14651858.CD003388.pub4

01/12/2013 Aripiprazole alone or in combination for acute mania PMID:24346956.0 https://doi.org/10.1002/14651858.CD005000.pub2

01/10/2014 Interventions for primary prevention of suicide in university and other post-secondary educational settings PMID:25353703.0 https://doi.org/10.1002/14651858.CD009439.pub2

01/11/2014 Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents PMID:25433518.0 https://doi.org/10.1002/14651858.CD008324.pub3

01/11/2014 Psychological, social and welfare interventions for psychological health and well-being of torture survivors PMID:25386846.0 https://doi.org/10.1002/14651858.CD009317.pub2

01/11/2014 Pharmacological interventions for somatoform disorders in adults PMID:25379990.0 https://doi.org/10.1002/14651858.CD010628.pub2

01/11/2014 Non-pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUPS) in adults PMID:25362239.0 https://doi.org/10.1002/14651858.CD011142.pub2

01/12/2015 Interventions for self-harm in children and adolescents PMID:26688129.0 https://doi.org/10.1002/14651858.CD012013

01/10/2016 S-adenosyl methionine (SAMe) for depression in adults PMID:27727432.0 https://doi.org/10.1002/14651858.CD011286.pub2

01/10/2016 Psychological therapies versus pharmacological interventions for panic disorder with or without agoraphobia in adults PMID:27730622.0 https://doi.org/10.1002/14651858.CD011170.pub2

01/10/2016 Psychological therapies for children and adolescents exposed to trauma PMID:27726123.0 https://doi.org/10.1002/14651858.CD012371

01/10/2017 Pharmacotherapy for social anxiety disorder (SAnD) PMID:29048739.0 https://doi.org/10.1002/14651858.CD001206.pub3

01/11/2017 Music therapy for depression PMID:29144545.0 https://doi.org/10.1002/14651858.CD004517.pub3

01/10/2018 Eszopiclone for insomnia PMID:30303519.0 https://doi.org/10.1002/14651858.CD010703.pub2

01/12/2018 Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease PMID:30566235.0 https://doi.org/10.1002/14651858.CD012346.pub2

01/12/2018 Psychological therapies for anxiety and depression in children and adolescents with long-term physical conditions PMID:30578633.0 https://doi.org/10.1002/14651858.CD012488.pub2

01/12/2018 Internet-based cognitive and behavioural therapies for post-traumatic stress disorder (PTSD) in adults PMID:30550643.0 https://doi.org/10.1002/14651858.CD011710.pub2

01/10/2019 Valproate for acute mania PMID:31621892.0 https://doi.org/10.1002/14651858.CD004052.pub2

01/10/2019 Exercise therapy for chronic fatigue syndrome PMID:31577366.0 https://doi.org/10.1002/14651858.CD003200.pub8

01/11/2019 Present-centered therapy (PCT) for post-traumatic stress disorder (PTSD) in adults PMID:31742672.0 https://doi.org/10.1002/14651858.CD012898.pub2

01/12/2019 Pharmacy-based management for depression in adults PMID:31868236.0 https://doi.org/10.1002/14651858.CD013299.pub2

01/12/2019 Couple and family therapies for post-traumatic stress disorder (PTSD) PMID:31797352.0 https://doi.org/10.1002/14651858.CD011257.pub2

01/12/2019 Pharmacological interventions for treatment-resistant depression in adults PMID:31846068.0 https://doi.org/10.1002/14651858.CD010557.pub2

Dementia and Cognitive Improvement Group

01/11/2011 Cognitive reframing for carers of people with dementia PMID:22071821.0 https://doi.org/10.1002/14651858.CD005318.pub2

01/12/2011 Naftidrofuryl for dementia PMID:22161372.0 https://doi.org/10.1002/14651858.CD002955.pub4

01/12/2012 Psychosocial interventions for reducing antipsychotic medication in care home residents PMID:23235663.0 https://doi.org/10.1002/14651858.CD008634.pub2

01/12/2012 Huperzine A for mild cognitive impairment PMID:23235666.0 https://doi.org/10.1002/14651858.CD008827.pub2

01/12/2020 Remotely delivered information, training and support for informal caregivers of people with dementia PMID:nan https://doi.org/10.1002/14651858.CD006440.pub3

01/12/2020 Souvenaid for Alzheimer's disease PMID:33320335.0 https://doi.org/10.1002/14651858.CD011679.pub2

01/11/2020 Pharmacotherapies for sleep disturbances in dementia PMID:33189083.0 https://doi.org/10.1002/14651858.CD009178.pub4

01/08/2020 Personally tailored activities for improving psychosocial outcomes for people with dementia in community settings PMID:32786083.0 https://doi.org/10.1002/14651858.CD010515.pub2

01/04/2020 Aspirin and other non-steroidal anti-inflammatory drugs for the prevention of dementia PMID:32352165.0 https://doi.org/10.1002/14651858.CD011459.pub2

01/04/2020 Simulated presence therapy for dementia PMID:32311774.0 https://doi.org/10.1002/14651858.CD011882.pub3

01/03/2020 Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment PMID:32119112.0 https://doi.org/10.1002/14651858.CD009628.pub2

01/02/2020 Computerised cognitive training for 12 or more weeks for maintaining cognitive function in cognitively healthy people in late life PMID:32104914.0 https://doi.org/10.1002/14651858.CD012277.pub3

01/02/2020 Cognitive training interventions for dementia and mild cognitive impairment in Parkinson’s disease PMID:32101639.0 https://doi.org/10.1002/14651858.CD011961.pub2

01/02/2020 Enhanced rehabilitation and care models for adults with dementia following hip fracture surgery PMID:32031676.0 https://doi.org/10.1002/14651858.CD010569.pub3

01/02/2020 Benzodiazepines for treatment of patients with delirium excluding those who are cared for in an intensive care unit PMID:32108325.0 https://doi.org/10.1002/14651858.CD012670.pub2

01/09/2019 Mini-Cog for the diagnosis of Alzheimer’s disease dementia and other dementias within a secondary care setting PMID:31521064.0 https://doi.org/10.1002/14651858.CD011414.pub2

01/04/2019 Interventions for preventing delirium in older people in institutional long-term care PMID:31012953.0 https://doi.org/10.1002/14651858.CD009537.pub3

01/03/2019 AD-8 for detection of dementia across a variety of healthcare settings PMID:30828783.0 https://doi.org/10.1002/14651858.CD011121.pub2

01/03/2019 Computerised cognitive training for maintaining cognitive function in cognitively healthy people in midlife PMID:30864746.0 https://doi.org/10.1002/14651858.CD012278.pub2

01/03/2019 Computerised cognitive training for preventing dementia in people with mild cognitive impairment PMID:30864747.0 https://doi.org/10.1002/14651858.CD012279.pub2

01/03/2019 Cognitive training for people with mild to moderate dementia PMID:30909318.0 https://doi.org/10.1002/14651858.CD013069.pub2

01/09/2018 Art therapy for people with dementia PMID:30215847.0 https://doi.org/10.1002/14651858.CD011073.pub2

01/09/2018 Modifying the consistency of food and fluids for swallowing difficulties in dementia PMID:30251253.0 https://doi.org/10.1002/14651858.CD011077.pub2

01/08/2018 Antidepressants for treating depression in dementia PMID:30168578.0 https://doi.org/10.1002/14651858.CD003944.pub2

01/08/2018 Mindfulness-based stress reduction for family carers of people with dementia PMID:30106471.0 https://doi.org/10.1002/14651858.CD012791.pub2

01/07/2018 Environmental and behavioural modifications for improving food and fluid intake in people with dementia PMID:30021248.0 https://doi.org/10.1002/14651858.CD011542.pub2

01/07/2018 Music-based therapeutic interventions for people with dementia PMID:30033623.0 https://doi.org/10.1002/14651858.CD003477.pub4

01/06/2018 Antipsychotics for treatment of delirium in hospitalised non-ICU patients PMID:29920656.0 https://doi.org/10.1002/14651858.CD005594.pub3

01/06/2018 Cholinesterase inhibitors for the treatment of delirium in non-ICU settings PMID:29952000.0 https://doi.org/10.1002/14651858.CD012494.pub2

01/05/2018 Pharmacological interventions for apathy in Alzheimer's disease PMID:29727467.0 https://doi.org/10.1002/14651858.CD012197.pub2

01/03/2018 Withdrawal versus continuation of long-term antipsychotic drug use for behavioural and psychological symptoms in older people with dementia PMID:29605970.0 https://doi.org/10.1002/14651858.CD007726.pub3

01/02/2018 Mini-Cog for the diagnosis of Alzheimer’s disease dementia and other dementias within a primary care setting PMID:29470861.0 https://doi.org/10.1002/14651858.CD011415.pub2

01/02/2018 Personally tailored activities for improving psychosocial outcomes for people with dementia in long-term care PMID:29438597.0 https://doi.org/10.1002/14651858.CD009812.pub2

01/06/2017 Assistive technology for memory support in dementia PMID:28602027.0 https://doi.org/10.1002/14651858.CD009627.pub2

01/06/2017 Effect of the treatment of Type 2 diabetes mellitus on the development of cognitive impairment and dementia PMID:28617932.0 https://doi.org/10.1002/14651858.CD003804.pub2

01/04/2017 Vitamin E for Alzheimer's dementia and mild cognitive impairment PMID:28418065.0 https://doi.org/10.1002/14651858.CD002854.pub5

01/03/2017 L-carnitine for cognitive enhancement in people without cognitive impairment PMID:28349514.0 https://doi.org/10.1002/14651858.CD009374.pub3

01/03/2017 CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI) PMID:28328043.0 https://doi.org/10.1002/14651858.CD010803.pub2

01/02/2017 Dance movement therapy for dementia PMID:28155990.0 https://doi.org/10.1002/14651858.CD011022.pub2

01/09/2016 Statin withdrawal in people with dementia PMID:27610945.0 https://doi.org/10.1002/14651858.CD012050.pub2

01/03/2016 Interventions for preventing delirium in hospitalised non-ICU patients PMID:26967259.0 https://doi.org/10.1002/14651858.CD005563.pub3

01/01/2016 Statins for the prevention of dementia PMID:26727124.0 https://doi.org/10.1002/14651858.CD003160.pub3

01/01/2016 Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care populations PMID:26760674.0 https://doi.org/10.1002/14651858.CD011145.pub2

01/09/2015 Rivastigmine for Alzheimer's disease PMID:26393402.0 https://doi.org/10.1002/14651858.CD001191.pub4

01/07/2015 Endoscopic third ventriculostomy (ETV) for idiopathic normal pressure hydrocephalus (iNPH) PMID:26222251.0 https://doi.org/10.1002/14651858.CD010033.pub2

01/06/2015 Regional Cerebral Blood Flow Single Photon Emission Computed Tomography for detection of Frontotemporal dementia in people with suspected dementia PMID:26102272.0 https://doi.org/10.1002/14651858.CD010896.pub2

01/05/2015 Opioids for agitation in dementia PMID:25972091.0 https://doi.org/10.1002/14651858.CD009705.pub2

01/04/2015 Aerobic exercise to improve cognitive function in older people without known cognitive impairment PMID:25900537.0 https://doi.org/10.1002/14651858.CD005381.pub4

01/04/2015 Exercise programs for people with dementia PMID:25874613.0 https://doi.org/10.1002/14651858.CD006489.pub4

01/04/2015 Latrepirdine for Alzheimer's disease PMID:25897825.0 https://doi.org/10.1002/14651858.CD009524.pub2

01/03/2015 Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI) PMID:25740785.0 https://doi.org/10.1002/14651858.CD010783.pub2

01/03/2015 Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within a secondary care setting PMID:25754745.0 https://doi.org/10.1002/14651858.CD010772.pub2

01/03/2015 Cholinesterase inhibitors for rarer dementias associated with neurological conditions PMID:25734590.0 https://doi.org/10.1002/14651858.CD009444.pub3

01/02/2015 Mini-Cog for the diagnosis of Alzheimer's disease dementia and other dementias within a community setting PMID:25922857.0 https://doi.org/10.1002/14651858.CD010860.pub2

01/01/2015 Case management approaches to home support for people with dementia PMID:25560977.0 https://doi.org/10.1002/14651858.CD008345.pub2

01/01/2015 Dopamine transporter imaging for the diagnosis of dementia with Lewy bodies PMID:25632881.0 https://doi.org/10.1002/14651858.CD010633.pub2

01/01/2015 18F-FDG PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI) PMID:25629415.0 https://doi.org/10.1002/14651858.CD010632.pub2

01/09/2014 Efficacy and experiences of telephone counselling for informal carers of people with dementia PMID:25177838.0 https://doi.org/10.1002/14651858.CD009126.pub2

01/07/2014 Statins for the treatment of dementia PMID:25004278.0 https://doi.org/10.1002/14651858.CD007514.pub3

01/07/2014 Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within a general practice (primary care) setting PMID:24990271.0 https://doi.org/10.1002/14651858.CD010771.pub2

01/07/2014 11C-PIB-PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI) PMID:25052054.0 https://doi.org/10.1002/14651858.CD010386.pub2

01/06/2014 Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI) PMID:24913723.0 https://doi.org/10.1002/14651858.CD008782.pub4

01/04/2014 Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within community dwelling populations PMID:24719028.0 https://doi.org/10.1002/14651858.CD010079.pub2

01/02/2014 Metal protein attenuating compounds for the treatment of Alzheimer's dementia PMID:24563468.0 https://doi.org/10.1002/14651858.CD005380.pub5

01/02/2014 Light therapy for improving cognition, activities of daily living, sleep, challenging behaviour, and psychiatric disturbances in dementia PMID:24574061.0 https://doi.org/10.1002/14651858.CD003946.pub4

01/01/2014 Respite care for people with dementia and their carers PMID:24435941.0 https://doi.org/10.1002/14651858.CD004396.pub3

01/01/2014 Psychological treatments for depression and anxiety in dementia and mild cognitive impairment PMID:24449085.0 https://doi.org/10.1002/14651858.CD009125.pub2

01/08/2013 Driving assessment for maintaining mobility and safety in drivers with dementia PMID:23990315.0 https://doi.org/10.1002/14651858.CD006222.pub4

01/06/2013 Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer's disease and vascular dementia PMID:23740535.0 https://doi.org/10.1002/14651858.CD003260.pub2

01/05/2013 Rivastigmine for vascular cognitive impairment PMID:23728651.0 https://doi.org/10.1002/14651858.CD004744.pub3

01/05/2013 Flow-regulated versus differential pressure-regulated shunt valves for adult patients with normal pressure hydrocephalus PMID:23728696.0 https://doi.org/10.1002/14651858.CD009706.pub2

01/09/2012 Cholinesterase inhibitors for mild cognitive impairment PMID:22972133.0 https://doi.org/10.1002/14651858.CD009132.pub2

01/07/2012 Hyperbaric oxygen therapy for vascular dementia PMID:22786527.0 https://doi.org/10.1002/14651858.CD009425.pub2

01/06/2012 Omega 3 fatty acid for the prevention of cognitive decline and dementia PMID:22696350.0 https://doi.org/10.1002/14651858.CD005379.pub3

01/03/2012 Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease PMID:22419314.0 https://doi.org/10.1002/14651858.CD006504.pub2

01/02/2012 Functional analysis-based interventions for challenging behaviour in dementia PMID:22336826.0 https://doi.org/10.1002/14651858.CD006929.pub2

01/02/2012 Cognitive stimulation to improve cognitive functioning in people with dementia PMID:22336813.0 https://doi.org/10.1002/14651858.CD005562.pub2

01/02/2012 Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease PMID:22336816.0 https://doi.org/10.1002/14651858.CD006378.pub2

01/04/2011 Carbohydrates for improving the cognitive performance of independent-living older adults with normal cognition or mild cognitive impairment PMID:21491398.0 https://doi.org/10.1002/14651858.CD007220.pub2

01/03/2011 Almitrine-Raubasine combination for dementia PMID:21412915.0 https://doi.org/10.1002/14651858.CD008068.pub2

01/02/2011 Interventions for preventing and reducing the use of physical restraints in long-term geriatric care PMID:21328295.0 https://doi.org/10.1002/14651858.CD007546.pub2

01/02/2011 Antidepressants for agitation and psychosis in dementia PMID:21328305.0 https://doi.org/10.1002/14651858.CD008191.pub2

01/01/2011 Cognition-based interventions for healthy older people and people with mild cognitive impairment PMID:21249675.0 https://doi.org/10.1002/14651858.CD006220.pub2

01/10/2015 Montreal Cognitive Assessment for the diagnosis of Alzheimer’s disease and other dementias PMID:26513331.0 https://doi.org/10.1002/14651858.CD010775.pub2

01/12/2015 Pharmacotherapy for chronic cognitive impairment in traumatic brain injury PMID:26624881.0 https://doi.org/10.1002/14651858.CD009221.pub2

01/11/2016 Antihypertensive withdrawal for the prevention of cognitive decline PMID:27802359.0 https://doi.org/10.1002/14651858.CD011971.pub2

01/11/2016 Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the early diagnosis of dementia across a variety of healthcare settings PMID:27869298.0 https://doi.org/10.1002/14651858.CD011333.pub2

01/12/2016 Palliative care interventions in advanced dementia PMID:27911489.0 https://doi.org/10.1002/14651858.CD011513.pub2

01/11/2017 18F PET with florbetapir for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI) PMID:29164603.0 https://doi.org/10.1002/14651858.CD012216.pub2

01/11/2017 18F PET with florbetaben for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI) PMID:29164600.0 https://doi.org/10.1002/14651858.CD012883

01/11/2017 18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI) PMID:29164602.0 https://doi.org/10.1002/14651858.CD012884

01/10/2018 Valproate preparations for agitation in dementia PMID:30293233.0 https://doi.org/10.1002/14651858.CD003945.pub4

01/11/2018 Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment PMID:30383288.0 https://doi.org/10.1002/14651858.CD011905.pub2

01/12/2018 Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life PMID:30556597.0 https://doi.org/10.1002/14651858.CD011906.pub2

01/12/2018 Traditional Chinese herbal medicine for vascular dementia PMID:30520514.0 https://doi.org/10.1002/14651858.CD010284.pub2

01/11/2019 Cerebrolysin for vascular dementia PMID:31710397.0 https://doi.org/10.1002/14651858.CD008900.pub3

01/11/2019 Animal-assisted therapy for dementia PMID:31763689.0 https://doi.org/10.1002/14651858.CD013243.pub2

01/12/2019 Addenbrooke’s Cognitive Examination III (ACE-III) and mini-ACE for the detection of dementia and mild cognitive impairment PMID:31846066.0 https://doi.org/10.1002/14651858.CD013282.pub2

Developmental, Psychosocial and Learning Problems Group

01/11/2011 Melatonin for non-respiratory sleep disorders in visually impaired children PMID:22071850.0 https://doi.org/10.1002/14651858.CD008473.pub2

01/11/2011 Omega-3 fatty acids supplementation for autism spectrum disorders (ASD) PMID:22071839.0 https://doi.org/10.1002/14651858.CD007992.pub2

01/12/2011 Intermittent iron supplementation for improving nutrition and development in children under 12 years of age PMID:22161444.0 https://doi.org/10.1002/14651858.CD009085.pub2

01/12/2011 Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years PMID:22161373.0 https://doi.org/10.1002/14651858.CD003018.pub3

01/12/2011 Home-based child development interventions for preschool children from socially disadvantaged families PMID:22161419.0 https://doi.org/10.1002/14651858.CD008131.pub2

01/12/2011 Auditory integration training and other sound therapies for autism spectrum disorders (ASD) PMID:22161380.0 https://doi.org/10.1002/14651858.CD003681.pub3

01/10/2012 Interventions for oropharyngeal dysphagia in children with neurological impairment PMID:23076958.0 https://doi.org/10.1002/14651858.CD009456.pub2

01/11/2012 Interventions for drooling in children with cerebral palsy PMID:23152263.0 https://doi.org/10.1002/14651858.CD008624.pub3

01/12/2012 Manipulative therapies for infantile colic PMID:23235617.0 https://doi.org/10.1002/14651858.CD004796.pub2

01/12/2012 Zinc supplementation for mental and motor development in children PMID:23235652.0 https://doi.org/10.1002/14651858.CD007991.pub2

01/12/2012 Psychological interventions for adults who have sexually offended or are at risk of offending PMID:23235646.0 https://doi.org/10.1002/14651858.CD007507.pub2

01/12/2020 Effects of oral vitamin D supplementation on linear growth and other health outcomes among children under five years of age PMID:33305842.0 https://doi.org/10.1002/14651858.CD012875.pub2

01/11/2020 Mechanically assisted walking training for walking, participation, and quality of life in children with cerebral palsy PMID:33202482.0 https://doi.org/10.1002/14651858.CD013114.pub2

01/10/2020 Household interventions for secondary prevention of domestic lead exposure in children PMID:33022752.0 https://doi.org/10.1002/14651858.CD006047.pub6

01/09/2020 Psychological interventions for antisocial personality disorder PMID:32880104.0 https://doi.org/10.1002/14651858.CD007668.pub3

01/09/2020 Pharmacological interventions for antisocial personality disorder PMID:32880105.0 https://doi.org/10.1002/14651858.CD007667.pub3

01/07/2020 Psychological interventions to foster resilience in healthcare professionals PMID:32627860.0 https://doi.org/10.1002/14651858.CD012527.pub2

01/07/2020 Psychological interventions to foster resilience in healthcare students PMID:32691879.0 https://doi.org/10.1002/14651858.CD013684

01/06/2020 Cognitive-behavioural therapy (CBT) interventions for young people aged 10 to 18 with harmful sexual behaviour PMID:32572950.0 https://doi.org/10.1002/14651858.CD009829.pub2

01/05/2020 Psychological therapies for people with borderline personality disorder PMID:32368793.0 https://doi.org/10.1002/14651858.CD012955.pub2

01/04/2020 Rinse-free hand wash for reducing absenteeism among preschool and school children PMID:32270476.0 https://doi.org/10.1002/14651858.CD012566.pub2

01/02/2020 Home fortification of foods with multiple micronutrient powders for health and nutrition in children under two years of age PMID:32107773.0 https://doi.org/10.1002/14651858.CD008959.pub3

01/01/2020 Caregiver involvement in interventions for improving children's dietary intake and physical activity behaviors PMID:31902132.0 https://doi.org/10.1002/14651858.CD012547.pub2

01/07/2019 Families and Schools Together (FAST) for improving outcomes for children and their families PMID:31425610.0 https://doi.org/10.1002/14651858.CD012760.pub2

01/06/2019 Social skills training for attention deficit hyperactivity disorder (ADHD) in children aged 5 to 18 years PMID:31222721.0 https://doi.org/10.1002/14651858.CD008223.pub3

01/06/2019 A realist review of which advocacy interventions work for which abused women under what circumstances PMID:31254283.0 https://doi.org/10.1002/14651858.CD013135.pub2

01/05/2019 Preventive lipid-based nutrient supplements given with complementary foods to infants and young children 6 to 23 months of age for health, nutrition, and developmental outcomes PMID:31046132.0 https://doi.org/10.1002/14651858.CD012611.pub3

01/04/2019 Constraint-induced movement therapy in children with unilateral cerebral palsy PMID:30932166.0 https://doi.org/10.1002/14651858.CD004149.pub3

01/03/2019 Probiotics to prevent infantile colic PMID:30865287.0 https://doi.org/10.1002/14651858.CD012473.pub2

01/02/2019 Effectiveness of provision of animal-source foods for supporting optimal growth and development in children 6 to 59 months of age PMID:30779870.0 https://doi.org/10.1002/14651858.CD012818.pub2

01/01/2019 Intermittent iron supplementation for reducing anaemia and its associated impairments in adolescent and adult menstruating women PMID:30699468.0 https://doi.org/10.1002/14651858.CD009218.pub3

01/08/2018 Lipid-based nutrient supplements for maternal, birth, and infant developmental outcomes PMID:30168868.0 https://doi.org/10.1002/14651858.CD012610.pub2

01/08/2018 Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults PMID:30091808.0 https://doi.org/10.1002/14651858.CD007813.pub3

01/07/2018 Diagnostic tests for autism spectrum disorder (ASD) in preschool children PMID:30075057.0 https://doi.org/10.1002/14651858.CD009044.pub2

01/07/2018 De-escalation techniques for managing non-psychosis induced aggression in adults PMID:30019748.0 https://doi.org/10.1002/14651858.CD012034.pub2

01/07/2018 Parent-mediated communication interventions for improving the communication skills of preschool children with non-progressive motor disorders PMID:30040119.0 https://doi.org/10.1002/14651858.CD012507.pub2

01/07/2018 Parent training interventions for parents with intellectual disability PMID:30004571.0 https://doi.org/10.1002/14651858.CD007987.pub3

01/06/2018 Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders PMID:29944175.0 https://doi.org/10.1002/14651858.CD007990.pub3

01/05/2018 Early intensive behavioral intervention (EIBI) for young children with autism spectrum disorders (ASD) PMID:29742275.0 https://doi.org/10.1002/14651858.CD009260.pub3

01/05/2018 Educational interventions for improving primary caregiver complementary feeding practices for children aged 24 months and under PMID:29775501.0 https://doi.org/10.1002/14651858.CD011768.pub2

01/05/2018 Interventions for childhood apraxia of speech PMID:29845607.0 https://doi.org/10.1002/14651858.CD006278.pub3

01/03/2018 The Neonatal Behavioral Assessment Scale (NBAS) and Newborn Behavioral Observations (NBO) system for supporting caregivers and improving outcomes in caregivers and their infants PMID:29537066.0 https://doi.org/10.1002/14651858.CD011754.pub2

01/03/2018 Physical activity, diet and other behavioural interventions for improving cognition and school achievement in children and adolescents with obesity or overweight PMID:29499084.0 https://doi.org/10.1002/14651858.CD009728.pub4

01/03/2018 Cognitive-behavioural interventions for attention deficit hyperactivity disorder (ADHD) in adults PMID:29566425.0 https://doi.org/10.1002/14651858.CD010840.pub2

01/08/2017 Atypical antipsychotics for disruptive behaviour disorders in children and youths PMID:28791693.0 https://doi.org/10.1002/14651858.CD008559.pub3

01/07/2017 Treadmill interventions in children under six years of age at risk of neuromotor delay PMID:28755534.0 https://doi.org/10.1002/14651858.CD009242.pub3

01/07/2017 Task-oriented interventions for children with developmental co-ordination disorder PMID:28758189.0 https://doi.org/10.1002/14651858.CD010914.pub2

01/06/2017 Exercise interventions for cerebral palsy PMID:28602046.0 https://doi.org/10.1002/14651858.CD011660.pub2

01/05/2017 Family therapy for autism spectrum disorders PMID:28509404.0 https://doi.org/10.1002/14651858.CD011894.pub2

01/03/2017 Dietary interventions for recurrent abdominal pain in childhood PMID:28334433.0 https://doi.org/10.1002/14651858.CD010972.pub2

01/03/2017 Pharmacological interventions for recurrent abdominal pain in childhood PMID:28262913.0 https://doi.org/10.1002/14651858.CD010973.pub2

01/03/2017 Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age PMID:28282701.0 https://doi.org/10.1002/14651858.CD008524.pub3

01/01/2017 Psychosocial interventions for recurrent abdominal pain in childhood PMID:28072460.0 https://doi.org/10.1002/14651858.CD010971.pub2

01/09/2016 Polyunsaturated fatty acids (PUFAs) for children with specific learning disorders PMID:27678554.0 https://doi.org/10.1002/14651858.CD009398.pub3

01/08/2016 Group-based parent training programmes for improving emotional and behavioural adjustment in young children PMID:27478983.0 https://doi.org/10.1002/14651858.CD003680.pub3

01/06/2016 Aripiprazole for autism spectrum disorders (ASD) PMID:27344135.0 https://doi.org/10.1002/14651858.CD009043.pub3

01/04/2016 Daily iron supplementation for improving anaemia, iron status and health in menstruating women PMID:27087396.0 https://doi.org/10.1002/14651858.CD009747.pub2

01/02/2016 Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents PMID:26844979.0 https://doi.org/10.1002/14651858.CD009996.pub2

01/09/2015 Clozapine for psychotic disorders in adults with intellectual disabilities PMID:26397173.0 https://doi.org/10.1002/14651858.CD010625.pub2

01/08/2015 Music for insomnia in adults PMID:26270746.0 https://doi.org/10.1002/14651858.CD010459.pub2

01/07/2015 Screening women for intimate partner violence in healthcare settings PMID:26200817.0 https://doi.org/10.1002/14651858.CD007007.pub3

01/05/2015 L-acetylcarnitine for treating fragile X syndrome PMID:25985235.0 https://doi.org/10.1002/14651858.CD010012.pub2

01/05/2015 Chelation for autism spectrum disorder (ASD) PMID:26114777.0 https://doi.org/10.1002/14651858.CD010766.pub2

01/04/2015 School-based education programmes for the prevention of child sexual abuse PMID:25876919.0 https://doi.org/10.1002/14651858.CD004380.pub3

01/04/2015 Behavioural and cognitive-behavioural interventions for outwardly-directed aggressive behaviour in people with intellectual disabilities PMID:25847633.0 https://doi.org/10.1002/14651858.CD003406.pub4

01/03/2015 Food supplementation for improving the physical and psychosocial health of socio-economically disadvantaged children aged three months to five years PMID:25739460.0 https://doi.org/10.1002/14651858.CD009924.pub2

01/03/2015 Non-speech oral motor treatment for children with developmental speech sound disorders PMID:25805060.0 https://doi.org/10.1002/14651858.CD009383.pub2

01/02/2015 Pharmacological interventions for those who have sexually offended or are at risk of offending PMID:25692326.0 https://doi.org/10.1002/14651858.CD007989.pub2

01/01/2015 Parent-infant psychotherapy for improving parental and infant mental health PMID:25569177.0 https://doi.org/10.1002/14651858.CD010534.pub2

01/09/2014 Centre-based day care for children younger than five years of age in high-income countries PMID:25247266.0 https://doi.org/10.1002/14651858.CD010544.pub2

01/09/2014 Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents PMID:25238582.0 https://doi.org/10.1002/14651858.CD006997.pub2

01/09/2014 Centre-based day care for children younger than five years of age in low- and middle-income countries PMID:25254354.0 https://doi.org/10.1002/14651858.CD010543.pub2

01/06/2014 Music therapy for people with autism spectrum disorder PMID:24936966.0 https://doi.org/10.1002/14651858.CD004381.pub3

01/05/2014 Zinc supplementation for preventing mortality, morbidity, and growth failure in children aged 6 months to 12 years of age PMID:24826920.0 https://doi.org/10.1002/14651858.CD009384.pub2

01/05/2014 Group-based parent training programmes for improving parental psychosocial health PMID:24838729.0 https://doi.org/10.1002/14651858.CD002020.pub4

01/04/2014 The WHO Health Promoting School framework for improving the health and well-being of students and their academic achievement PMID:24737131.0 https://doi.org/10.1002/14651858.CD008958.pub2

01/03/2014 Interventions based on the Theory of Mind cognitive model for autism spectrum disorder (ASD) PMID:24652601.0 https://doi.org/10.1002/14651858.CD008785.pub2

01/03/2014 Auditory-verbal therapy for promoting spoken language development in children with permanent hearing impairments PMID:24619508.0 https://doi.org/10.1002/14651858.CD010100.pub2

01/01/2014 Kinship care for the safety, permanency, and well-being of children removed from the home for maltreatment PMID:24488572.0 https://doi.org/10.1002/14651858.CD006546.pub3

01/08/2013 Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD) PMID:23959778.0 https://doi.org/10.1002/14651858.CD004677.pub3

01/08/2013 Fundoplication versus postoperative medication for gastro-oesophageal reflux in children with neurological impairment undergoing gastrostomy PMID:23986351.0 https://doi.org/10.1002/14651858.CD006151.pub3

01/07/2013 Psychoanalytic/psychodynamic psychotherapy for children and adolescents who have been sexually abused PMID:23904184.0 https://doi.org/10.1002/14651858.CD008162.pub2

01/07/2013 Gastrostomy feeding versus oral feeding alone for children with cerebral palsy PMID:23900969.0 https://doi.org/10.1002/14651858.CD003943.pub3

01/06/2013 Educational and skills-based interventions for preventing relationship and dating violence in adolescents and young adults PMID:23780745.0 https://doi.org/10.1002/14651858.CD004534.pub3

01/06/2013 Iron therapy for improving psychomotor development and cognitive function in children under the age of three with iron deficiency anaemia PMID:23744449.0 https://doi.org/10.1002/14651858.CD001444.pub2

01/06/2013 Specialist home-based nursing services for children with acute and chronic illnesses PMID:23771694.0 https://doi.org/10.1002/14651858.CD004383.pub3

01/04/2013 Parent-mediated early intervention for young children with autism spectrum disorders (ASD) PMID:23633377.0 https://doi.org/10.1002/14651858.CD009774.pub2

01/04/2013 Massage for promoting mental and physical health in typically developing infants under the age of six months PMID:23633323.0 https://doi.org/10.1002/14651858.CD005038.pub3

01/04/2013 'Scared Straight' and other juvenile awareness programs for preventing juvenile delinquency PMID:23862186.0 https://doi.org/10.1002/14651858.CD002796.pub2

01/04/2013 Pharmacological interventions for self-injurious behaviour in adults with intellectual disabilities PMID:23633366.0 https://doi.org/10.1002/14651858.CD009084.pub2

01/02/2013 Restorative justice conferencing for reducing recidivism in young offenders (aged 7 to 21) PMID:23450592.0 https://doi.org/10.1002/14651858.CD008898.pub2

01/08/2012 Music education for improving reading skills in children and adolescents with dyslexia PMID:22895983.0 https://doi.org/10.1002/14651858.CD009133.pub2

01/07/2012 Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents PMID:22786509.0 https://doi.org/10.1002/14651858.CD007986.pub2

01/07/2012 Social skills groups for people aged 6 to 21 with autism spectrum disorders (ASD) PMID:22786515.0 https://doi.org/10.1002/14651858.CD008511.pub2

01/06/2012 Crisis interventions for people with borderline personality disorder PMID:22696385.0 https://doi.org/10.1002/14651858.CD009353.pub2

01/06/2012 Community-based supplementary feeding for promoting the growth of children under five years of age in low and middle income countries PMID:22696347.0 https://doi.org/10.1002/14651858.CD005039.pub3

01/05/2012 Cognitive-behavioural interventions for children who have been sexually abused PMID:22592679.0 https://doi.org/10.1002/14651858.CD001930.pub3

01/04/2012 Intravenous secretin for autism spectrum disorders (ASD) PMID:22513913.0 https://doi.org/10.1002/14651858.CD003495.pub3

01/03/2012 Tricyclic antidepressants for autism spectrum disorders (ASD) in children and adolescents PMID:22419332.0 https://doi.org/10.1002/14651858.CD008372.pub2

01/02/2012 Behavioural and cognitive-behavioural group-based parenting programmes for early-onset conduct problems in children aged 3 to 12 years PMID:22336837.0 https://doi.org/10.1002/14651858.CD008225.pub2

01/05/2011 Folic acid for fragile X syndrome PMID:21563169.0 https://doi.org/10.1002/14651858.CD008476.pub2

01/03/2011 Individual and group based parenting programmes for improving psychosocial outcomes for teenage parents and their children PMID:21412881.0 https://doi.org/10.1002/14651858.CD002964.pub2

01/02/2011 Cognitive behavioural therapy for men who physically abuse their female partner PMID:17636823.0 https://doi.org/10.1002/14651858.CD006048.pub2

01/10/2015 Pharmacological interventions for cognitive decline in people with Down syndrome PMID:26513128.0 https://doi.org/10.1002/14651858.CD011546.pub2

01/11/2015 Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD) PMID:26599576.0 https://doi.org/10.1002/14651858.CD009885.pub2

01/11/2015 Sleep positioning systems for children with cerebral palsy PMID:26524348.0 https://doi.org/10.1002/14651858.CD009257.pub2

01/12/2015 Advocacy interventions to reduce or eliminate violence and promote the physical and psychosocial well-being of women who experience intimate partner abuse PMID:26632986.0 https://doi.org/10.1002/14651858.CD005043.pub3

01/10/2016 Hyperbaric oxygen therapy for people with autism spectrum disorder (ASD) PMID:27737490.0 https://doi.org/10.1002/14651858.CD010922.pub2

01/10/2017 Bupropion for attention deficit hyperactivity disorder (ADHD) in adults PMID:28965364.0 https://doi.org/10.1002/14651858.CD009504.pub2

01/11/2017 Methylphenidate for children and adolescents with autism spectrum disorder PMID:29159857.0 https://doi.org/10.1002/14651858.CD011144.pub2

01/11/2017 Point-of-use fortification of foods with micronutrient powders containing iron in children of preschool and school-age PMID:29168569.0 https://doi.org/10.1002/14651858.CD009666.pub2

01/10/2018 Parent-mediated interventions for promoting communication and language development in young children with Down syndrome PMID:30321454.0 https://doi.org/10.1002/14651858.CD012089.pub2

01/10/2018 Dietary modifications for infantile colic PMID:30306546.0 https://doi.org/10.1002/14651858.CD011029.pub2

01/11/2018 Communication interventions for autism spectrum disorder in minimally verbal children PMID:30395694.0 https://doi.org/10.1002/14651858.CD012324.pub2

01/11/2018 Phonics training for English-speaking poor readers PMID:30480759.0 https://doi.org/10.1002/14651858.CD009115.pub3

01/11/2018 Community-based supplementary feeding for food insecure, vulnerable and malnourished populations – an overview of systematic reviews PMID:30480324.0 https://doi.org/10.1002/14651858.CD010578.pub2

01/10/2019 Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy PMID:31591703.0 https://doi.org/10.1002/14651858.CD001408.pub2

01/11/2019 Video feedback for parental sensitivity and attachment security in children under five years PMID:31782528.0 https://doi.org/10.1002/14651858.CD012348.pub2

01/12/2019 Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis PMID:31801180.0 https://doi.org/10.1002/14651858.CD011260.pub2

01/12/2019 Parent training programmes for managing infantile colic PMID:31794639.0 https://doi.org/10.1002/14651858.CD012459.pub2

01/12/2019 Beginning reading interventions for children and adolescents with intellectual disability PMID:31805208.0 https://doi.org/10.1002/14651858.CD011359.pub2

01/12/2019 Equivalent schedules of intradermal fractional dose versus intramuscular full dose of inactivated polio vaccine for prevention of poliomyelitis PMID:31858595.0 https://doi.org/10.1002/14651858.CD011780.pub2

Drugs and Alcohol Group

01/10/2011 Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence PMID:21975742.0 https://doi.org/10.1002/14651858.CD004147.pub4

01/11/2011 Mentoring adolescents to prevent drug and alcohol use PMID:22071836.0 https://doi.org/10.1002/14651858.CD007381.pub2

01/12/2011 Heroin maintenance for chronic heroin-dependent individuals PMID:22161378.0 https://doi.org/10.1002/14651858.CD003410.pub4

01/12/2011 Antidepressants for cocaine dependence and problematic cocaine use PMID:22161371.0 https://doi.org/10.1002/14651858.CD002950.pub3

01/12/2012 Managed alcohol as a harm reduction intervention for alcohol addiction in populations at high risk for substance abuse PMID:23235633.0 https://doi.org/10.1002/14651858.CD006747.pub2

01/11/2020 Maintenance agonist treatments for opiate-dependent pregnant women PMID:33165953.0 https://doi.org/10.1002/14651858.CD006318.pub4

01/03/2020 Alcoholics Anonymous and other 12-step programs for alcohol use disorder PMID:32159228.0 https://doi.org/10.1002/14651858.CD012880.pub2

01/02/2020 Dihydrocodeine for detoxification and maintenance treatment in individuals with opiate use disorders PMID:32068247.0 https://doi.org/10.1002/14651858.CD012254.pub2

01/03/2019 Family-based prevention programmes for alcohol use in young people PMID:30888061.0 https://doi.org/10.1002/14651858.CD012287.pub2

01/06/2018 Pharmacological therapies for management of opium withdrawal PMID:29929212.0 https://doi.org/10.1002/14651858.CD007522.pub2

01/04/2018 Antidepressants for the treatment of people with co-occurring depression and alcohol dependence PMID:29688573.0 https://doi.org/10.1002/14651858.CD008581.pub2

01/03/2018 Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users PMID:29543325.0 https://doi.org/10.1002/14651858.CD011481.pub2

01/02/2018 Effectiveness of brief alcohol interventions in primary care populations PMID:29476653.0 https://doi.org/10.1002/14651858.CD004148.pub4

01/09/2017 Personalised digital interventions for reducing hazardous and harmful alcohol consumption in community-dwelling populations PMID:28944453.0 https://doi.org/10.1002/14651858.CD011479.pub2

01/09/2017 Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs PMID:28922449.0 https://doi.org/10.1002/14651858.CD012021.pub2

01/05/2017 Opioid antagonists with minimal sedation for opioid withdrawal PMID:28553701.0 https://doi.org/10.1002/14651858.CD002021.pub4

01/04/2017 Supervised dosing with a long-acting opioid medication in the management of opioid dependence PMID:28447766.0 https://doi.org/10.1002/14651858.CD011983.pub2

01/02/2017 Buprenorphine for managing opioid withdrawal PMID:28220474.0 https://doi.org/10.1002/14651858.CD002025.pub5

01/09/2016 Psychosocial interventions for psychostimulant misuse PMID:27684277.0 https://doi.org/10.1002/14651858.CD011866.pub2

01/09/2016 Psychostimulant drugs for cocaine dependence PMID:27670244.0 https://doi.org/10.1002/14651858.CD007380.pub4

01/05/2016 Alpha2-adrenergic agonists for the management of opioid withdrawal PMID:27140827.0 https://doi.org/10.1002/14651858.CD002024.pub5

01/05/2016 Psychosocial interventions for cannabis use disorder PMID:27149547.0 https://doi.org/10.1002/14651858.CD005336.pub4

01/05/2016 Opioid agonist treatment for pharmaceutical opioid dependent people PMID:27157143.0 https://doi.org/10.1002/14651858.CD011117.pub2

01/03/2016 Antipsychotic medications for cocaine dependence PMID:26992929.0 https://doi.org/10.1002/14651858.CD006306.pub3

01/01/2016 Brief school-based interventions and behavioural outcomes for substance-using adolescents PMID:26787125.0 https://doi.org/10.1002/14651858.CD008969.pub3

01/06/2015 Pharmacological interventions for drug-using offenders PMID:26035084.0 https://doi.org/10.1002/14651858.CD010862.pub2

01/05/2015 Dopamine agonists for the treatment of cocaine dependence PMID:26014366.0 https://doi.org/10.1002/14651858.CD003352.pub4

01/05/2015 Psychosocial interventions for benzodiazepine harmful use, abuse or dependence PMID:26106751.0 https://doi.org/10.1002/14651858.CD009652.pub2

01/04/2015 Anticonvulsants for cocaine dependence PMID:25882271.0 https://doi.org/10.1002/14651858.CD006754.pub4

01/04/2015 Psychosocial interventions for pregnant women in outpatient illicit drug treatment programs compared to other interventions PMID:25835053.0 https://doi.org/10.1002/14651858.CD006037.pub3

01/06/2014 Maintenance treatments for opiate-dependent adolescents PMID:24957634.0 https://doi.org/10.1002/14651858.CD007210.pub3

01/04/2014 Detoxification treatments for opiate dependent adolescents PMID:24777492.0 https://doi.org/10.1002/14651858.CD006749.pub3

01/02/2014 Anticonvulsants for alcohol dependence PMID:24523233.0 https://doi.org/10.1002/14651858.CD008544.pub2

01/09/2013 Efficacy of psychostimulant drugs for amphetamine abuse or dependence PMID:23996457.0 https://doi.org/10.1002/14651858.CD009695.pub2

01/06/2013 QTc interval screening for cardiac risk in methadone treatment of opioid dependence PMID:23787716.0 https://doi.org/10.1002/14651858.CD008939.pub2

01/06/2013 Media campaigns for the prevention of illicit drug use in young people PMID:23740538.0 https://doi.org/10.1002/14651858.CD009287.pub2

01/06/2013 Slow-release oral morphine as maintenance therapy for opioid dependence PMID:23740540.0 https://doi.org/10.1002/14651858.CD009879.pub2

01/06/2013 Magnesium for alcohol withdrawal PMID:23740536.0 https://doi.org/10.1002/14651858.CD008358.pub2

01/02/2013 Methadone at tapered doses for the management of opioid withdrawal PMID:23450540.0 https://doi.org/10.1002/14651858.CD003409.pub4

01/01/2013 Pharmacological therapies for maintenance treatments of opium dependence PMID:23440817.0 https://doi.org/10.1002/14651858.CD007775.pub2

01/09/2011 Universal multi-component prevention programs for alcohol misuse in young people PMID:21901732.0 https://doi.org/10.1002/14651858.CD009307

01/09/2011 Universal family-based prevention programs for alcohol misuse in young people PMID:21901733.0 https://doi.org/10.1002/14651858.CD009308

01/09/2011 Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification PMID:21901695.0 https://doi.org/10.1002/14651858.CD005031.pub4

01/08/2011 Oral substitution treatment of injecting opioid users for prevention of HIV infection PMID:21833948.0 https://doi.org/10.1002/14651858.CD004145.pub4

01/08/2011 Brief interventions for heavy alcohol users admitted to general hospital wards PMID:21833953.0 https://doi.org/10.1002/14651858.CD005191.pub3

01/06/2011 Efficacy and safety of pharmacological interventions for the treatment of the Alcohol Withdrawal Syndrome PMID:21678378.0 https://doi.org/10.1002/14651858.CD008537.pub2

01/05/2011 Motivational interviewing for substance abuse PMID:21563163.0 https://doi.org/10.1002/14651858.CD008063.pub2

01/05/2011 Universal school-based prevention programs for alcohol misuse in young people PMID:21563171.0 https://doi.org/10.1002/14651858.CD009113

01/04/2011 Oral naltrexone maintenance treatment for opioid dependence PMID:21491383.0 https://doi.org/10.1002/14651858.CD001333.pub4

01/11/2014 Restricting or banning alcohol advertising to reduce alcohol consumption in adults and adolescents PMID:25369459.0 https://doi.org/10.1002/14651858.CD010704.pub2

01/12/2014 Universal school-based prevention for illicit drug use PMID:25435250.0 https://doi.org/10.1002/14651858.CD003020.pub3

01/11/2018 Baclofen for alcohol use disorder PMID:30484285.0 https://doi.org/10.1002/14651858.CD012557.pub2

01/12/2018 Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users PMID:30521696.0 https://doi.org/10.1002/14651858.CD009269.pub4

01/12/2018 Cognitive-behavioural treatment for amphetamine-type stimulants (ATS)-use disorders PMID:30577083.0 https://doi.org/10.1002/14651858.CD011315.pub2

01/10/2019 Interventions for drug-using offenders with co-occurring mental health problems PMID:31588993.0 https://doi.org/10.1002/14651858.CD010901.pub3

01/11/2019 Baclofen for alcohol withdrawal PMID:31689723.0 https://doi.org/10.1002/14651858.CD008502.pub6

01/11/2019 Psychological interventions for co-occurring depression and substance use disorders PMID:31769015.0 https://doi.org/10.1002/14651858.CD009501.pub2

01/12/2019 Interventions for female drug-using offenders PMID:31834635.0 https://doi.org/10.1002/14651858.CD010910.pub3

Epilepsy Group

01/11/2011 The effects of anaesthetic agents on cortical mapping during neurosurgical procedures involving eloquent areas of the brain PMID:22071831.0 https://doi.org/10.1002/14651858.CD006679.pub2

01/10/2012 Pregabalin monotherapy for epilepsy PMID:23076957.0 https://doi.org/10.1002/14651858.CD009429.pub2

01/11/2020 Pharmacological treatment for continuous spike-wave during slow wave sleep syndrome and Landau-Kleffner Syndrome PMID:33174224.0 https://doi.org/10.1002/14651858.CD013132.pub2

01/11/2020 Rufinamide add-on therapy for drug-resistant epilepsy PMID:33179247.0 https://doi.org/10.1002/14651858.CD011772.pub3

01/10/2020 Strategies for improving adherence to antiepileptic drug treatment in people with epilepsy PMID:33089492.0 https://doi.org/10.1002/14651858.CD008312.pub4

01/09/2020 Psychological treatments for people with epilepsy PMID:nan https://doi.org/10.1002/14651858.CD012081.pub3

01/07/2020 Vigabatrin add-on therapy for drug-resistant focal epilepsy PMID:32730657.0 https://doi.org/10.1002/14651858.CD007302.pub3

01/07/2020 Levetiracetam add-on for drug-resistant focal epilepsy PMID:nan https://doi.org/10.1002/14651858.CD001901.pub3

01/07/2020 Zonisamide add-on therapy for focal epilepsy PMID:32715463.0 https://doi.org/10.1002/14651858.CD001416.pub5

01/06/2020 Lamotrigine add-on therapy for drug-resistant generalised tonic-clonic seizures PMID:32609387.0 https://doi.org/10.1002/14651858.CD007783.pub3

01/06/2020 Ketogenic diets for drug-resistant epilepsy PMID:32588435.0 https://doi.org/10.1002/14651858.CD001903.pub5

01/05/2020 Stiripentol add-on therapy for drug-resistant focal epilepsy PMID:32468572.0 https://doi.org/10.1002/14651858.CD009887.pub5

01/04/2020 Antiepileptic drugs as prophylaxis for postcraniotomy seizures PMID:32343399.0 https://doi.org/10.1002/14651858.CD007286.pub5

01/04/2020 EEG for children with complex febrile seizures PMID:32270497.0 https://doi.org/10.1002/14651858.CD009196.pub5

01/04/2020 Clonazepam add-on therapy for drug-resistant epilepsy PMID:32309880.0 https://doi.org/10.1002/14651858.CD012253.pub3

01/04/2020 Treatments for the prevention of Sudden Unexpected Death in Epilepsy (SUDEP) PMID:32239759.0 https://doi.org/10.1002/14651858.CD011792.pub3

01/03/2020 Oxcarbazepine add-on for drug-resistant focal epilepsy PMID:32129501.0 https://doi.org/10.1002/14651858.CD012433.pub2

01/03/2020 Lamotrigine add-on therapy for drug-resistant focal epilepsy PMID:32196639.0 https://doi.org/10.1002/14651858.CD001909.pub3

01/01/2020 Rapid versus slow withdrawal of antiepileptic drugs PMID:31990368.0 https://doi.org/10.1002/14651858.CD005003.pub3

01/08/2019 Felbamate add-on therapy for drug-resistant focal epilepsy PMID:31425617.0 https://doi.org/10.1002/14651858.CD008295.pub5

01/08/2019 Sulthiame add-on therapy for epilepsy PMID:31453633.0 https://doi.org/10.1002/14651858.CD009472.pub4

01/07/2019 Pregabalin add-on for drug-resistant focal epilepsy PMID:31287157.0 https://doi.org/10.1002/14651858.CD005612.pub4

01/07/2019 Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review PMID:31318037.0 https://doi.org/10.1002/14651858.CD001911.pub4

01/06/2019 Surgery for epilepsy PMID:31237346.0 https://doi.org/10.1002/14651858.CD010541.pub3

01/06/2019 Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review PMID:31233229.0 https://doi.org/10.1002/14651858.CD012065.pub3

01/03/2019 Brivaracetam add-on therapy for drug-resistant epilepsy PMID:30920649.0 https://doi.org/10.1002/14651858.CD011501.pub2

01/02/2019 Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents PMID:30734919.0 https://doi.org/10.1002/14651858.CD003032.pub4

01/01/2019 Topiramate for juvenile myoclonic epilepsy PMID:30687937.0 https://doi.org/10.1002/14651858.CD010008.pub4

01/08/2018 Sodium valproate versus phenytoin monotherapy for epilepsy: an individual participant data review PMID:30091458.0 https://doi.org/10.1002/14651858.CD001769.pub4

01/06/2018 Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review PMID:29952431.0 https://doi.org/10.1002/14651858.CD001031.pub4

01/03/2018 Care delivery and self-management strategies for children with epilepsy PMID:29493780.0 https://doi.org/10.1002/14651858.CD006245.pub4

01/01/2018 Drug management for acute tonic-clonic convulsions including convulsive status epilepticus in children PMID:29320603.0 https://doi.org/10.1002/14651858.CD001905.pub3

01/07/2017 Deep brain and cortical stimulation for epilepsy PMID:28718878.0 https://doi.org/10.1002/14651858.CD008497.pub3

01/05/2017 Antiepileptic drugs for the treatment of infants with severe myoclonic epilepsy PMID:28521067.0 https://doi.org/10.1002/14651858.CD010483.pub4

01/02/2017 Propofol versus thiopental sodium for the treatment of refractory status epilepticus PMID:28155226.0 https://doi.org/10.1002/14651858.CD009202.pub4

01/02/2017 Prophylactic drug management for febrile seizures in children PMID:28225210.0 https://doi.org/10.1002/14651858.CD003031.pub3

01/08/2016 Polyunsaturated fatty acid supplementation for drug-resistant epilepsy PMID:27536971.0 https://doi.org/10.1002/14651858.CD011014.pub2

01/08/2016 Transcranial magnetic stimulation for the treatment of epilepsy PMID:27513825.0 https://doi.org/10.1002/14651858.CD011025.pub2

01/08/2016 Melatonin as add-on treatment for epilepsy PMID:27513702.0 https://doi.org/10.1002/14651858.CD006967.pub4

01/05/2016 Immediate antiepileptic drug treatment, versus placebo, deferred, or no treatment for first unprovoked seizure PMID:27150433.0 https://doi.org/10.1002/14651858.CD007144.pub2

01/05/2016 Pharmacological treatment for Kleine-Levin syndrome PMID:27153153.0 https://doi.org/10.1002/14651858.CD006685.pub4

01/05/2016 Antiepileptic drugs for the primary and secondary prevention of seizures in viral encephalitis PMID:27209627.0 https://doi.org/10.1002/14651858.CD010247.pub3

01/04/2016 Antiepileptic drugs for the primary and secondary prevention of seizures after intracranial venous thrombosis PMID:27098266.0 https://doi.org/10.1002/14651858.CD005501.pub4

01/02/2016 Care delivery and self management strategies for adults with epilepsy PMID:26842929.0 https://doi.org/10.1002/14651858.CD006244.pub3

01/09/2015 Pharmacological interventions for epilepsy in people with intellectual disabilities PMID:26333428.0 https://doi.org/10.1002/14651858.CD005399.pub3

01/09/2015 Non-pharmacological interventions for people with epilepsy and intellectual disabilities PMID:26355236.0 https://doi.org/10.1002/14651858.CD005502.pub3

01/08/2015 Pharmacological treatments for preventing epilepsy following traumatic head injury PMID:26259048.0 https://doi.org/10.1002/14651858.CD009900.pub2

01/07/2015 Neuropsychological and psychological interventions for people with newly diagnosed epilepsy PMID:26198593.0 https://doi.org/10.1002/14651858.CD011311.pub2

01/06/2015 Corticosteroids including ACTH for childhood epilepsy other than epileptic spasms PMID:26086765.0 https://doi.org/10.1002/14651858.CD005222.pub3

01/06/2015 Lacosamide add-on therapy for partial epilepsy PMID:26077821.0 https://doi.org/10.1002/14651858.CD008841.pub2

01/04/2015 Vagus nerve stimulation for partial seizures PMID:25835947.0 https://doi.org/10.1002/14651858.CD002896.pub2

01/02/2015 Early versus late antiepileptic drug withdrawal for people with epilepsy in remission PMID:25922863.0 https://doi.org/10.1002/14651858.CD001902.pub2

01/09/2014 Comparison of antiepileptic drugs, no treatment, or placebo for children with benign epilepsy with centro temporal spikes PMID:25190506.0 https://doi.org/10.1002/14651858.CD006779.pub2

01/03/2014 Cannabinoids for epilepsy PMID:24595491.0 https://doi.org/10.1002/14651858.CD009270.pub3

01/03/2014 Sulthiame monotherapy for epilepsy PMID:24609897.0 https://doi.org/10.1002/14651858.CD010062.pub2

01/02/2014 Psychological and behavioural treatments for adults with non-epileptic attack disorder PMID:24519702.0 https://doi.org/10.1002/14651858.CD006370.pub2

01/01/2014 Antiepileptic drugs for the primary and secondary prevention of seizures after stroke PMID:24464793.0 https://doi.org/10.1002/14651858.CD005398.pub3

01/06/2013 Antiepileptic drugs for the primary and secondary prevention of seizures after subarachnoid haemorrhage PMID:23740537.0 https://doi.org/10.1002/14651858.CD008710.pub2

01/06/2013 Treatment of infantile spasms PMID:23740534.0 https://doi.org/10.1002/14651858.CD001770.pub3

01/06/2013 Immunomodulatory interventions for focal epilepsy syndromes PMID:23803963.0 https://doi.org/10.1002/14651858.CD009945.pub2

01/03/2013 Calcium antagonists as an add-on therapy for drug-resistant epilepsy PMID:23543516.0 https://doi.org/10.1002/14651858.CD002750.pub2

01/02/2013 Treatment of Lennox-Gastaut syndrome PMID:23450537.0 https://doi.org/10.1002/14651858.CD003277.pub3

01/08/2011 Antiepileptic drugs for treating seizures in adults with brain tumours PMID:21833969.0 https://doi.org/10.1002/14651858.CD008586.pub2

01/10/2014 Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child PMID:25354543.0 https://doi.org/10.1002/14651858.CD010236.pub2

01/12/2014 Antidepressants for people with epilepsy and depression PMID:25464360.0 https://doi.org/10.1002/14651858.CD010682.pub2

01/11/2015 Vigabatrin versus carbamazepine monotherapy for epilepsy PMID:26580100.0 https://doi.org/10.1002/14651858.CD008781.pub3

01/12/2015 Interventions for psychotic symptoms concomitant with epilepsy PMID:26690687.0 https://doi.org/10.1002/14651858.CD006118.pub3

01/11/2016 Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child PMID:27819746.0 https://doi.org/10.1002/14651858.CD010224.pub2

01/12/2016 Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy PMID:27933615.0 https://doi.org/10.1002/14651858.CD007124.pub5

01/10/2017 Eslicarbazepine acetate add-on for drug-resistant partial epilepsy PMID:29067682.0 https://doi.org/10.1002/14651858.CD008907.pub3

01/10/2017 Yoga for epilepsy PMID:28982217.0 https://doi.org/10.1002/14651858.CD001524.pub3 01/10/2017 The role of high-frequency oscillations in epilepsy surgery planning PMID:28981957.0 https://doi.org/10.1002/14651858.CD010235.pub3

01/11/2017 Chloral hydrate as a sedating agent for neurodiagnostic procedures in children PMID:29099542.0 https://doi.org/10.1002/14651858.CD011786.pub2

01/12/2017 Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data PMID:29243813.0 https://doi.org/10.1002/14651858.CD011412.pub3

01/10/2018 Gabapentin add-on treatment for drug-resistant focal epilepsy PMID:30357813.0 https://doi.org/10.1002/14651858.CD001415.pub3

01/10/2018 Oxcarbazepine versus phenytoin monotherapy for epilepsy: an individual participant data review PMID:30350354.0 https://doi.org/10.1002/14651858.CD003615.pub4

01/11/2018 Subpial transection surgery for epilepsy PMID:30383287.0 https://doi.org/10.1002/14651858.CD008153.pub4

01/12/2018 Treatment of epilepsy for people with Alzheimer's disease PMID:30570742.0 https://doi.org/10.1002/14651858.CD011922.pub3

01/10/2019 Topiramate add-on therapy for drug-resistant focal epilepsy PMID:31642054.0 https://doi.org/10.1002/14651858.CD001417.pub4

01/10/2019 Treatments for seizures in catamenial (menstrual-related) epilepsy PMID:31608992.0 https://doi.org/10.1002/14651858.CD013225.pub2

01/10/2019 Tiagabine add-on therapy for drug-resistant focal epilepsy PMID:31608990.0 https://doi.org/10.1002/14651858.CD001908.pub4

01/10/2019 Antiepileptic drugs for seizure control in people with neurocysticercosis PMID:31608991.0 https://doi.org/10.1002/14651858.CD009027.pub3

01/10/2019 Clobazam add-on therapy for drug-resistant epilepsy PMID:31638272.0 https://doi.org/10.1002/14651858.CD004154.pub5

01/11/2019 Clonazepam monotherapy for treating people with newly diagnosed epilepsy PMID:31742671.0 https://doi.org/10.1002/14651858.CD013028.pub2

01/12/2019 Losigamone add-on therapy for focal epilepsy PMID:31823350.0 https://doi.org/10.1002/14651858.CD009324.pub5

01/12/2019 Intravenous immunoglobulins for epilepsy PMID:31792946.0 https://doi.org/10.1002/14651858.CD008557.pub4

Movement Disorders Group

01/11/2011 Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies PMID:22071848.0 https://doi.org/10.1002/14651858.CD008454.pub2

01/11/2011 Anti-hypertensive drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies and clinical trials PMID:22071852.0 https://doi.org/10.1002/14651858.CD008535.pub2

01/11/2011 Helicobacter pylori eradication for Parkinson's disease PMID:22071847.0 https://doi.org/10.1002/14651858.CD008453.pub2

01/10/2014 Pharmacotherapy for sleep bruxism PMID:25338726.0 https://doi.org/10.1002/14651858.CD005578.pub2

01/10/2015 Interventions for fatigue in Parkinson's disease PMID:26447539.0 https://doi.org/10.1002/14651858.CD010925.pub2

01/11/2015 Intrathecal baclofen for treating spasticity in children with cerebral palsy PMID:26563961.0 https://doi.org/10.1002/14651858.CD004552.pub2

01/12/2015 Alprazolam for essential tremor PMID:26638213.0 https://doi.org/10.1002/14651858.CD009681.pub2

01/10/2016 Botulinum toxin type A versus botulinum toxin type B for cervical dystonia PMID:27782297.0 https://doi.org/10.1002/14651858.CD004314.pub3

01/10/2016 Pregabalin for essential tremor PMID:27763691.0 https://doi.org/10.1002/14651858.CD009682.pub2

01/11/2020 Botulinum toxin type A therapy for hemifacial spasm PMID:33211908.0 https://doi.org/10.1002/14651858.CD004899.pub3

01/11/2020 Botulinum toxin type A therapy for cervical dystonia PMID:33180963.0 https://doi.org/10.1002/14651858.CD003633.pub4

01/11/2020 Botulinum toxin type A therapy for blepharospasm PMID:33211907.0 https://doi.org/10.1002/14651858.CD004900.pub3

01/07/2020 GLP-1 receptor agonists for Parkinson's disease PMID:32700772.0 https://doi.org/10.1002/14651858.CD012990.pub2

01/01/2019 Deep brain stimulation for dystonia PMID:30629283.0 https://doi.org/10.1002/14651858.CD012405.pub2

01/01/2019 Iron for the treatment of restless legs syndrome PMID:30609006.0 https://doi.org/10.1002/14651858.CD007834.pub3

01/01/2018 Botulinum toxin for motor and phonic tics in Tourette's syndrome PMID:29304272.0 https://doi.org/10.1002/14651858.CD012285.pub2

01/08/2017 Zonisamide for essential tremor PMID:28836659.0 https://doi.org/10.1002/14651858.CD009684.pub2

01/04/2017 Topiramate for essential tremor PMID:28409827.0 https://doi.org/10.1002/14651858.CD009683.pub2

01/03/2017 Benzodiazepines for restless legs syndrome PMID:28319266.0 https://doi.org/10.1002/14651858.CD006939.pub2

01/07/2016 Transcranial direct current stimulation (tDCS) for idiopathic Parkinson's disease PMID:27425786.0 https://doi.org/10.1002/14651858.CD010916.pub2

01/07/2016 Speech therapy for children with dysarthria acquired before three years of age PMID:27428115.0 https://doi.org/10.1002/14651858.CD006937.pub3

01/06/2016 Opioids for restless legs syndrome PMID:27355187.0 https://doi.org/10.1002/14651858.CD006941.pub2

01/05/2016 Botulinum toxin type B for cervical dystonia PMID:27176573.0 https://doi.org/10.1002/14651858.CD004315.pub3

01/09/2015 Treadmill training for patients with Parkinson's disease PMID:26363646.0 https://doi.org/10.1002/14651858.CD007830.pub4

01/06/2014 Physiotherapy for Parkinson's disease: a comparison of techniques PMID:24936965.0 https://doi.org/10.1002/14651858.CD002815.pub2

01/06/2014 Creatine for Parkinson's disease PMID:24934384.0 https://doi.org/10.1002/14651858.CD009646.pub2

01/09/2013 Physiotherapy versus placebo or no intervention in Parkinson's disease PMID:24018704.0 https://doi.org/10.1002/14651858.CD002817.pub4

01/09/2013 Botulinum toxin for masseter hypertrophy PMID:24018587.0 https://doi.org/10.1002/14651858.CD007510.pub3

01/08/2012 Speech and language therapy versus placebo or no intervention for speech problems in Parkinson's disease PMID:22895930.0 https://doi.org/10.1002/14651858.CD002812.pub2

01/08/2012 Comparison of speech and language therapy techniques for speech problems in Parkinson's disease PMID:22895931.0 https://doi.org/10.1002/14651858.CD002814.pub2

01/02/2012 Whole-body vibration training for patients with neurodegenerative disease PMID:22336858.0 https://doi.org/10.1002/14651858.CD009097.pub2

01/03/2011 Dopamine agonists for restless legs syndrome PMID:21412893.0 https://doi.org/10.1002/14651858.CD006009.pub2

01/02/2011 Levodopa for restless legs syndrome PMID:21328278.0 https://doi.org/10.1002/14651858.CD005504.pub2

Multiple Sclerosis and Rare Diseases of the CNS Group

01/10/2011 Natalizumab for relapsing remitting multiple sclerosis PMID:21975773.0 https://doi.org/10.1002/14651858.CD007621.pub2

01/12/2011 Statins for multiple sclerosis PMID:22161428.0 https://doi.org/10.1002/14651858.CD008386.pub3

01/12/2012 Oral versus intravenous steroids for treatment of relapses in multiple sclerosis PMID:23235634.0 https://doi.org/10.1002/14651858.CD006921.pub3

01/12/2013 Rituximab for relapsing-remitting multiple sclerosis PMID:24310855.0 https://doi.org/10.1002/14651858.CD009130.pub3

01/12/2013 Daclizumab for relapsing remitting multiple sclerosis PMID:24363032.0 https://doi.org/10.1002/14651858.CD008127.pub4

01/12/2013 Pharmacological treatment for memory disorder in multiple sclerosis PMID:24343792.0 https://doi.org/10.1002/14651858.CD008876.pub3

01/12/2014 Biologics, colchicine, corticosteroids, immunosuppressants and interferon-alpha for Neuro-Behçet's Syndrome PMID:25521793.0 https://doi.org/10.1002/14651858.CD010729.pub2

01/10/2015 Sodium channel blockers for neuroprotection in multiple sclerosis PMID:26486929.0 https://doi.org/10.1002/14651858.CD010422.pub2

01/06/2020 Ventriculo-peritoneal shunting devices for hydrocephalus PMID:32542676.0 https://doi.org/10.1002/14651858.CD012726.pub2

01/05/2020 Dietary interventions for multiple sclerosis-related outcomes PMID:32428983.0 https://doi.org/10.1002/14651858.CD004192.pub4

01/06/2019 Route of antibiotic prophylaxis for prevention of cerebrospinal fluid-shunt infection PMID:31163089.0 https://doi.org/10.1002/14651858.CD012902.pub2

01/05/2019 Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency (CCSVI) in people with multiple sclerosis PMID:31150100.0 https://doi.org/10.1002/14651858.CD009903.pub3

01/01/2019 Rehabilitation for people with multiple sclerosis: an overview of Cochrane Reviews PMID:30637728.0 https://doi.org/10.1002/14651858.CD012732.pub2

01/09/2018 Vitamin D for the management of multiple sclerosis PMID:30246874.0 https://doi.org/10.1002/14651858.CD008422.pub3

01/04/2017 Treatment with disease-modifying drugs for people with a first clinical attack suggestive of multiple sclerosis PMID:28440858.0 https://doi.org/10.1002/14651858.CD012200.pub2

01/04/2016 Alemtuzumab for multiple sclerosis PMID:27082500.0 https://doi.org/10.1002/14651858.CD011203.pub2

01/04/2016 Fingolimod for relapsing-remitting multiple sclerosis PMID:27091121.0 https://doi.org/10.1002/14651858.CD009371.pub2

01/03/2016 Memory rehabilitation for people with multiple sclerosis PMID:27004596.0 https://doi.org/10.1002/14651858.CD008754.pub3

01/03/2016 Teriflunomide for multiple sclerosis PMID:27003123.0 https://doi.org/10.1002/14651858.CD009882.pub3

01/09/2015 Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis PMID:26384035.0 https://doi.org/10.1002/14651858.CD011381.pub2

01/09/2015 Exercise therapy for fatigue in multiple sclerosis PMID:26358158.0 https://doi.org/10.1002/14651858.CD009956.pub2

01/04/2015 Telerehabilitation for persons with multiple sclerosis PMID:25854331.0 https://doi.org/10.1002/14651858.CD010508.pub2

01/02/2014 Mycophenolate mofetil for relapsing-remitting multiple sclerosis PMID:24505016.0 https://doi.org/10.1002/14651858.CD010242.pub2

01/08/2013 Laquinimod for multiple sclerosis PMID:23922214.0 https://doi.org/10.1002/14651858.CD010475.pub2

01/06/2013 Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis PMID:23744561.0 https://doi.org/10.1002/14651858.CD008933.pub2

01/05/2013 Mitoxantrone for multiple sclerosis PMID:23728638.0 https://doi.org/10.1002/14651858.CD002127.pub3

01/02/2013 Non pharmacological interventions for spasticity in multiple sclerosis PMID:23450612.0 https://doi.org/10.1002/14651858.CD009974.pub2

01/05/2012 Carnitine for fatigue in multiple sclerosis PMID:22592719.0 https://doi.org/10.1002/14651858.CD007280.pub3

01/04/2012 Sildenafil citrate for erectile dysfunction in patients with multiple sclerosis PMID:22513975.0 https://doi.org/10.1002/14651858.CD009427.pub2

01/01/2012 Interferon beta for secondary progressive multiple sclerosis PMID:22258960.0 https://doi.org/10.1002/14651858.CD005181.pub3

01/02/2011 Pharmacologic treatment of depression in multiple sclerosis PMID:21328292.0 https://doi.org/10.1002/14651858.CD007295.pub2

01/11/2016 Interferons-beta versus glatiramer acetate for relapsing-remitting multiple sclerosis PMID:27880972.0 https://doi.org/10.1002/14651858.CD009333.pub3

01/10/2017 Intravenous immunoglobulin for the treatment of childhood encephalitis PMID:28967695.0 https://doi.org/10.1002/14651858.CD011367.pub2

01/11/2017 Alemtuzumab versus interferon beta 1a for relapsing-remitting multiple sclerosis PMID:29178444.0 https://doi.org/10.1002/14651858.CD010968.pub2

01/12/2017 Respiratory muscle training for multiple sclerosis PMID:29267988.0 https://doi.org/10.1002/14651858.CD009424.pub2

01/10/2018 Information provision for people with multiple sclerosis PMID:30317542.0 https://doi.org/10.1002/14651858.CD008757.pub3

01/12/2018 Non-pharmacological interventions for chronic pain in multiple sclerosis PMID:30567012.0 https://doi.org/10.1002/14651858.CD012622.pub2

01/10/2019 Palliative care interventions for people with multiple sclerosis PMID:31637711.0 https://doi.org/10.1002/14651858.CD012936.pub2

01/11/2019 Interventions for preventing falls in people with multiple sclerosis PMID:31778221.0 https://doi.org/10.1002/14651858.CD012475.pub2

Neuromuscular Group

01/12/2011 Physical training for McArdle disease PMID:22161416.0 https://doi.org/10.1002/14651858.CD007931.pub2

01/11/2012 Recombinant human insulin-like growth factor I (rhIGF-I) for the treatment of amyotrophic lateral sclerosis/motor neuron disease PMID:23152212.0 https://doi.org/10.1002/14651858.CD002064.pub3

01/12/2012 Medical and surgical treatment for ocular myasthenia PMID:23235620.0 https://doi.org/10.1002/14651858.CD005081.pub3

01/12/2012 Intravenous immunoglobulin for myasthenia gravis PMID:23235588.0 https://doi.org/10.1002/14651858.CD002277.pub4

01/12/2012 Treatment for meralgia paraesthetica PMID:23235604.0 https://doi.org/10.1002/14651858.CD004159.pub3

01/12/2012 Creatine for amyotrophic lateral sclerosis/motor neuron disease PMID:23235621.0 https://doi.org/10.1002/14651858.CD005225.pub3

01/12/2012 Treatment for paraneoplastic neuropathies PMID:23235647.0 https://doi.org/10.1002/14651858.CD007625.pub2

01/12/2012 Decompressive surgery for treating nerve damage in leprosy PMID:23235638.0 https://doi.org/10.1002/14651858.CD006983.pub3

01/10/2013 Surgical interventions for the early management of Bell's palsy PMID:24132718.0 https://doi.org/10.1002/14651858.CD007468.pub3

01/10/2013 Chinese herbal medicine for diabetic peripheral neuropathy PMID:24096743.0 https://doi.org/10.1002/14651858.CD007796.pub3

01/10/2013 Thymectomy for non-thymomatous myasthenia gravis PMID:24122674.0 https://doi.org/10.1002/14651858.CD008111.pub2

01/12/2013 Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy PMID:24379104.0 https://doi.org/10.1002/14651858.CD001797.pub3

01/12/2013 Mechanical insufflation-exsufflation for people with neuromuscular disorders PMID:24374746.0 https://doi.org/10.1002/14651858.CD010044.pub2

01/12/2013 Non-antiepileptic drugs for trigeminal neuralgia PMID:24297506.0 https://doi.org/10.1002/14651858.CD004029.pub4

01/12/2013 Immunotherapy for idiopathic lumbosacral plexopathy PMID:24379134.0 https://doi.org/10.1002/14651858.CD009722.pub2

01/10/2014 Treatment for speech disorder in Friedreich ataxia and other hereditary ataxia syndromes PMID:25348587.0 https://doi.org/10.1002/14651858.CD008953.pub2

01/10/2014 Acetylcholinesterase inhibitor treatment for myasthenia gravis PMID:25310725.0 https://doi.org/10.1002/14651858.CD006986.pub3

01/11/2014 Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V) PMID:25391139.0 https://doi.org/10.1002/14651858.CD003458.pub5

01/11/2014 Treatment for thoracic outlet syndrome PMID:25427003.0 https://doi.org/10.1002/14651858.CD007218.pub3

01/12/2014 Interventions for fatigue in peripheral neuropathy PMID:25519471.0 https://doi.org/10.1002/14651858.CD008146.pub2 01/12/2014 Nocturnal mechanical ventilation for chronic hypoventilation in patients with neuromuscular and chest wall disorders PMID:25503955.0 https://doi.org/10.1002/14651858.CD001941.pub3

01/12/2014 Ephedrine for myasthenia gravis, neonatal myasthenia and the congenital myasthenic syndromes PMID:25515947.0 https://doi.org/10.1002/14651858.CD010028.pub2

01/12/2014 Treatment for cryoglobulinemic and non-cryoglobulinemic peripheral neuropathy associated with hepatitis C virus infection PMID:25525951.0 https://doi.org/10.1002/14651858.CD010404.pub2

01/10/2015 Surgery for scoliosis in Duchenne muscular dystrophy PMID:26423318.0 https://doi.org/10.1002/14651858.CD005375.pub4

01/11/2015 Treatment for dysphagia (swallowing difficulties) in hereditary ataxia PMID:26564018.0 https://doi.org/10.1002/14651858.CD010169.pub2

01/12/2015 Ascorbic acid for the treatment of Charcot-Marie-Tooth disease PMID:26662471.0 https://doi.org/10.1002/14651858.CD011952

01/10/2016 Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies PMID:27701752.0 https://doi.org/10.1002/14651858.CD002827.pub4

01/10/2016 Corticosteroids for Guillain-Barré syndrome PMID:27775812.0 https://doi.org/10.1002/14651858.CD001446.pub5

01/11/2016 Treatment for ulnar neuropathy at the elbow PMID:27845501.0 https://doi.org/10.1002/14651858.CD006839.pub4

01/12/2016 Antibiotics for the neurological complications of Lyme disease PMID:27931077.0 https://doi.org/10.1002/14651858.CD006978.pub2

01/09/2020 Magnesium for skeletal muscle cramps PMID:32956536.0 https://doi.org/10.1002/14651858.CD009402.pub3

01/05/2020 Interventions for congenital talipes equinovarus (clubfoot) PMID:32412098.0 https://doi.org/10.1002/14651858.CD008602.pub4

01/04/2020 Pharmacological treatment for familial amyloid polyneuropathy PMID:32311072.0 https://doi.org/10.1002/14651858.CD012395.pub2

01/01/2020 Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barré syndrome PMID:31981368.0 https://doi.org/10.1002/14651858.CD008630.pub5

01/01/2020 Drug treatment for spinal muscular atrophy types II and III PMID:32006461.0 https://doi.org/10.1002/14651858.CD006282.pub5

01/09/2019 Respiratory muscle training in children and adults with neuromuscular disease PMID:31487757.0 https://doi.org/10.1002/14651858.CD011711.pub2

01/09/2019 Antiviral treatment for Bell's palsy (idiopathic facial paralysis) PMID:31486071.0 https://doi.org/10.1002/14651858.CD001869.pub9

01/06/2019 Acetyl-L-carnitine for the treatment of diabetic peripheral neuropathy PMID:31201734.0 https://doi.org/10.1002/14651858.CD011265.pub2

01/04/2019 Medical treatment for botulism PMID:30993666.0 https://doi.org/10.1002/14651858.CD008123.pub4 01/03/2019 Physical exercise training for type 3 spinal muscular atrophy PMID:30821348.0 https://doi.org/10.1002/14651858.CD012120.pub2

01/02/2018 Absorbable versus non-absorbable sutures for skin closure after carpal tunnel decompression surgery PMID:29390170.0 https://doi.org/10.1002/14651858.CD011757.pub2

01/01/2018 Treatment of fatigue in amyotrophic lateral sclerosis/motor neuron disease PMID:29293261.0 https://doi.org/10.1002/14651858.CD011005.pub2

01/08/2017 Low-level laser therapy for carpal tunnel syndrome PMID:nan https://doi.org/10.1002/14651858.CD012765

01/07/2017 Immunotherapy for diabetic amyotrophy PMID:28746752.0 https://doi.org/10.1002/14651858.CD006521.pub4

01/06/2017 Tramadol for neuropathic pain in adults PMID:28616956.0 https://doi.org/10.1002/14651858.CD003726.pub4

01/06/2017 Drug therapy for chronic idiopathic axonal polyneuropathy PMID:28631805.0 https://doi.org/10.1002/14651858.CD003456.pub3

01/05/2017 Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy PMID:28481421.0 https://doi.org/10.1002/14651858.CD003280.pub5

01/02/2017 Plasma exchange for Guillain-Barré syndrome PMID:28241090.0 https://doi.org/10.1002/14651858.CD001798.pub3

01/01/2017 Interventions to prevent and treat corticosteroid-induced osteoporosis and prevent osteoporotic fractures in Duchenne muscular dystrophy PMID:28117876.0 https://doi.org/10.1002/14651858.CD010899.pub2

01/01/2017 Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews PMID:28084646.0 https://doi.org/10.1002/14651858.CD010369.pub2

01/01/2017 Gamma aminobutyric acid (GABA) modulators for amyotrophic lateral sclerosis/motor neuron disease PMID:28067943.0 https://doi.org/10.1002/14651858.CD006049.pub2

01/01/2017 Symptomatic treatments for amyotrophic lateral sclerosis/motor neuron disease PMID:28072907.0 https://doi.org/10.1002/14651858.CD011776.pub2

01/08/2016 Pharmacological treatments for Friedreich ataxia PMID:27572719.0 https://doi.org/10.1002/14651858.CD007791.pub4

01/07/2016 Corticosteroids for Bell's palsy (idiopathic facial paralysis) PMID:27428352.0 https://doi.org/10.1002/14651858.CD001942.pub5

01/05/2016 Corticosteroids for treating nerve damage in leprosy PMID:27210895.0 https://doi.org/10.1002/14651858.CD005491.pub3

01/05/2016 Corticosteroids for the treatment of Duchenne muscular dystrophy PMID:27149418.0 https://doi.org/10.1002/14651858.CD003725.pub4

01/02/2016 Interventions for dysphagia in long-term, progressive muscle disease PMID:26859621.0 https://doi.org/10.1002/14651858.CD004303.pub4

01/02/2016 Rehabilitation following carpal tunnel release PMID:26884379.0 https://doi.org/10.1002/14651858.CD004158.pub3

01/08/2015 Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy PMID:26305459.0 https://doi.org/10.1002/14651858.CD003906.pub4

01/06/2015 Treatment for inclusion body myositis PMID:nan https://doi.org/10.1002/14651858.CD001555.pub5

01/05/2015 Treatment for postpolio syndrome PMID:25984923.0 https://doi.org/10.1002/14651858.CD007818.pub3

01/04/2015 Quinine for muscle cramps PMID:25842375.0 https://doi.org/10.1002/14651858.CD005044.pub3

01/04/2015 Pharmacological treatment for pain in Guillain-Barré syndrome PMID:25855461.0 https://doi.org/10.1002/14651858.CD009950.pub3

01/03/2015 Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy PMID:25739040.0 https://doi.org/10.1002/14651858.CD003217.pub5

01/03/2015 Treatment for IgG and IgA paraproteinaemic neuropathy PMID:25803231.0 https://doi.org/10.1002/14651858.CD005376.pub3

01/03/2015 Physical rehabilitation for critical illness myopathy and neuropathy PMID:25737049.0 https://doi.org/10.1002/14651858.CD010942.pub2

01/09/2014 Intravenous immunoglobulin for Guillain-Barré syndrome PMID:25238327.0 https://doi.org/10.1002/14651858.CD002063.pub6

01/03/2014 Interventions for preventing neuropathy caused by cisplatin and related compounds PMID:24687190.0 https://doi.org/10.1002/14651858.CD005228.pub4

01/02/2014 Antiviral treatment for preventing postherpetic neuralgia PMID:24500927.0 https://doi.org/10.1002/14651858.CD006866.pub3

01/01/2014 Interventions for preventing critical illness polyneuropathy and critical illness myopathy PMID:24477672.0 https://doi.org/10.1002/14651858.CD006832.pub3

01/01/2014 Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia PMID:24385423.0 https://doi.org/10.1002/14651858.CD007115.pub3

01/01/2014 Endoscopic release for carpal tunnel syndrome PMID:24482073.0 https://doi.org/10.1002/14651858.CD008265.pub2

01/10/2017 Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease PMID:28982219.0 https://doi.org/10.1002/14651858.CD004427.pub4

01/08/2013 Topiramate for neuropathic pain and fibromyalgia in adults PMID:23996081.0 https://doi.org/10.1002/14651858.CD008314.pub3

01/06/2013 Drug therapy for pain in amyotrophic lateral sclerosis or motor neuron disease PMID:23740607.0 https://doi.org/10.1002/14651858.CD005226.pub3

01/06/2013 Creatine for treating muscle disorders PMID:23740606.0 https://doi.org/10.1002/14651858.CD004760.pub4

01/05/2013 Therapeutic exercise for people with amyotrophic lateral sclerosis or motor neuron disease PMID:23728653.0 https://doi.org/10.1002/14651858.CD005229.pub3

01/05/2013 Repetitive transcranial magnetic stimulation for the treatment of amyotrophic lateral sclerosis or motor neuron disease PMID:23728676.0 https://doi.org/10.1002/14651858.CD008554.pub3

01/03/2013 Corticosteroids for preventing postherpetic neuralgia PMID:23543541.0 https://doi.org/10.1002/14651858.CD005582.pub4

01/03/2013 Therapeutic ultrasound for carpal tunnel syndrome PMID:23543580.0 https://doi.org/10.1002/14651858.CD009601.pub2

01/08/2012 Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis PMID:22895935.0 https://doi.org/10.1002/14651858.CD003643.pub4

01/07/2012 Splinting for carpal tunnel syndrome PMID:22786532.0 https://doi.org/10.1002/14651858.CD010003

01/06/2012 Treatment for POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes) syndrome PMID:22696361.0 https://doi.org/10.1002/14651858.CD006828.pub3

01/06/2012 Enhanced glucose control for preventing and treating diabetic neuropathy PMID:22696371.0 https://doi.org/10.1002/14651858.CD007543.pub2

01/06/2012 Exercise and mobilisation interventions for carpal tunnel syndrome PMID:22696387.0 https://doi.org/10.1002/14651858.CD009899

01/04/2012 Treatment for cramps in amyotrophic lateral sclerosis/motor neuron disease PMID:22513921.0 https://doi.org/10.1002/14651858.CD004157.pub2

01/02/2012 Lacosamide for neuropathic pain and fibromyalgia in adults PMID:22336864.0 https://doi.org/10.1002/14651858.CD009318.pub2

01/02/2012 Treatment for spasticity in amyotrophic lateral sclerosis/motor neuron disease PMID:22336799.0 https://doi.org/10.1002/14651858.CD004156.pub4

01/02/2012 Hyperbaric oxygen therapy for Bell's palsy PMID:22336830.0 https://doi.org/10.1002/14651858.CD007288.pub2

01/01/2012 Ergonomic positioning or equipment for treating carpal tunnel syndrome PMID:22259003.0 https://doi.org/10.1002/14651858.CD009600

01/01/2012 Non-drug therapies for lower limb muscle cramps PMID:22258986.0 https://doi.org/10.1002/14651858.CD008496.pub2

01/09/2011 Neurosurgical interventions for the treatment of classical trigeminal neuralgia PMID:21901707.0 https://doi.org/10.1002/14651858.CD007312.pub2

01/05/2011 Treatment for sialorrhea (excessive saliva) in people with motor neuron disease/amyotrophic lateral sclerosis PMID:21563158.0 https://doi.org/10.1002/14651858.CD006981.pub2

01/03/2011 Vaccination for preventing postherpetic neuralgia PMID:21412911.0 https://doi.org/10.1002/14651858.CD007795.pub2

01/02/2011 Treatment for Lambert-Eaton myasthenic syndrome PMID:21328260.0 https://doi.org/10.1002/14651858.CD003279.pub3

01/01/2011 Enteral tube feeding for amyotrophic lateral sclerosis/motor neuron disease PMID:21249659.0 https://doi.org/10.1002/14651858.CD004030.pub3

01/11/2017 Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy PMID:29185258.0 https://doi.org/10.1002/14651858.CD002062.pub4

01/12/2017 Invasive versus non-invasive ventilation for acute respiratory failure in neuromuscular disease and chest wall disorders PMID:29199768.0 https://doi.org/10.1002/14651858.CD008380.pub2

01/12/2017 Oxcarbazepine for neuropathic pain PMID:29199767.0 https://doi.org/10.1002/14651858.CD007963.pub3

01/10/2018 Interventions for preventing and treating cardiac complications in Duchenne and Becker muscular dystrophy and X-linked dilated cardiomyopathy PMID:30326162.0 https://doi.org/10.1002/14651858.CD009068.pub3

01/12/2018 Acupuncture and related interventions for the treatment of symptoms associated with carpal tunnel syndrome PMID:30521680.0 https://doi.org/10.1002/14651858.CD011215.pub2

01/10/2019 Interventions for idiopathic toe walking PMID:31587271.0 https://doi.org/10.1002/14651858.CD012363.pub2

01/10/2019 Assisted standing for Duchenne muscular dystrophy PMID:31606891.0 https://doi.org/10.1002/14651858.CD011550.pub2

01/12/2019 Strength training and aerobic exercise training for muscle disease PMID:31808555.0 https://doi.org/10.1002/14651858.CD003907.pub5

01/12/2019 Cell-based therapies for amyotrophic lateral sclerosis/motor neuron disease PMID:31853962.0 https://doi.org/10.1002/14651858.CD011742.pub3

01/12/2019 Drug treatment for spinal muscular atrophy type I PMID:31825542.0 https://doi.org/10.1002/14651858.CD006281.pub5

Schizophrenia Group

01/12/2011 Day hospital versus admission for acute psychiatric disorders PMID:22161384.0 https://doi.org/10.1002/14651858.CD004026.pub2

01/10/2012 Information and communication technology in patient education and support for people with schizophrenia PMID:23076932.0 https://doi.org/10.1002/14651858.CD007198.pub2

01/11/2012 Management of sexual dysfunction due to antipsychotic drug therapy PMID:23152218.0 https://doi.org/10.1002/14651858.CD003546.pub3

01/11/2012 Bromperidol decanoate (depot) for schizophrenia PMID:23152208.0 https://doi.org/10.1002/14651858.CD001719.pub4

01/11/2012 Benzodiazepines for schizophrenia PMID:23152236.0 https://doi.org/10.1002/14651858.CD006391.pub2

01/11/2012 Flupenthixol versus placebo for schizophrenia PMID:23152280.0 https://doi.org/10.1002/14651858.CD009777.pub2

01/10/2013 Dance therapy for schizophrenia PMID:24092546.0 https://doi.org/10.1002/14651858.CD006868.pub3

01/10/2013 User-held personalised information for routine care of people with severe mental illness PMID:24096715.0 https://doi.org/10.1002/14651858.CD001711.pub2

01/10/2013 Atypical antipsychotics for psychosis in adolescents PMID:24129841.0 https://doi.org/10.1002/14651858.CD009582.pub2

01/11/2013 Quetiapine versus other atypical antipsychotics for schizophrenia PMID:24249315.0 https://doi.org/10.1002/14651858.CD006625.pub3

01/11/2013 Pimozide for schizophrenia or related psychoses PMID:24194433.0 https://doi.org/10.1002/14651858.CD001949.pub3

01/11/2013 Collaborative care approaches for people with severe mental illness PMID:24190251.0 https://doi.org/10.1002/14651858.CD009531.pub2

01/11/2013 Haloperidol versus placebo for schizophrenia PMID:24242360.0 https://doi.org/10.1002/14651858.CD003082.pub3

01/12/2013 Anticholinergic medication for non-clozapine neuroleptic-induced hypersalivation in people with schizophrenia PMID:24353163.0 https://doi.org/10.1002/14651858.CD009546.pub2

01/10/2014 Virtual reality for treatment compliance for people with serious mental illness PMID:25300174.0 https://doi.org/10.1002/14651858.CD009928.pub2

01/10/2014 Perphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia PMID:25290157.0 https://doi.org/10.1002/14651858.CD009369.pub2

01/10/2014 Cannabis and schizophrenia PMID:25314586.0 https://doi.org/10.1002/14651858.CD004837.pub3

01/10/2015 Lithium for schizophrenia PMID:26509923.0 https://doi.org/10.1002/14651858.CD003834.pub3

01/10/2015 Yoga versus standard care for schizophrenia PMID:26488850.0 https://doi.org/10.1002/14651858.CD010554.pub2

01/10/2015 Cognitive behavioural therapy (brief versus standard duration) for schizophrenia PMID:26488686.0 https://doi.org/10.1002/14651858.CD010646.pub3

01/11/2015 Asenapine versus placebo for schizophrenia PMID:26599405.0 https://doi.org/10.1002/14651858.CD011458.pub2

01/12/2015 'As required' medication regimens for seriously mentally ill people in hospital PMID:26689942.0 https://doi.org/10.1002/14651858.CD003441.pub3

01/12/2015 Crisis intervention for people with severe mental illnesses PMID:26633650.0 https://doi.org/10.1002/14651858.CD001087.pub5

01/12/2015 Zuclopenthixol versus placebo for schizophrenia PMID:26624987.0 https://doi.org/10.1002/14651858.CD010598.pub2

01/10/2016 Bifeprunox versus placebo for schizophrenia PMID:27732740.0 https://doi.org/10.1002/14651858.CD012029.pub2

01/11/2016 Haloperidol plus promethazine for psychosis-induced aggression PMID:27885664.0 https://doi.org/10.1002/14651858.CD005146.pub3

01/11/2016 Valproate for schizophrenia PMID:27884042.0 https://doi.org/10.1002/14651858.CD004028.pub4

01/11/2016 Haloperidol for long-term aggression in psychosis PMID:27889922.0 https://doi.org/10.1002/14651858.CD009830.pub2

01/12/2016 Implementation of treatment guidelines for specialist mental health care PMID:27977851.0 https://doi.org/10.1002/14651858.CD009780.pub3

01/12/2016 Risperidone versus placebo for schizophrenia PMID:27977041.0 https://doi.org/10.1002/14651858.CD006918.pub3

01/12/2016 Droperidol for psychosis-induced aggression or agitation PMID:27976370.0 https://doi.org/10.1002/14651858.CD002830.pub3

01/10/2017 Different communication strategies for disclosing a diagnosis of schizophrenia and related disorders PMID:29064090.0 https://doi.org/10.1002/14651858.CD011707.pub2

01/11/2017 Zuclopenthixol dihydrochloride for schizophrenia PMID:29144549.0 https://doi.org/10.1002/14651858.CD005474.pub2

01/10/2018 Chlorpromazine versus piperacetazine for schizophrenia PMID:30378678.0 https://doi.org/10.1002/14651858.CD011709.pub2

01/10/2018 Occupational therapy delivered by specialists versus non-specialists for people with schizophrenia PMID:30293234.0 https://doi.org/10.1002/14651858.CD012398.pub2

01/11/2018 Cognitive behavioural therapy plus standard care versus standard care plus other psychosocial treatments for people with schizophrenia PMID:30480760.0 https://doi.org/10.1002/14651858.CD008712.pub3

01/11/2020 Specialised early intervention teams for recent-onset psychosis PMID:33135811.0 https://doi.org/10.1002/14651858.CD013288.pub2

01/11/2020 Specialised early intervention teams (extended time) for recent-onset psychosis PMID:33135812.0 https://doi.org/10.1002/14651858.CD013287.pub2

01/08/2020 Maintenance treatment with antipsychotic drugs for schizophrenia PMID:32840872.0 https://doi.org/10.1002/14651858.CD008016.pub3

01/07/2020 Psychological interventions for psychosis in adolescents PMID:32633858.0 https://doi.org/10.1002/14651858.CD009533.pub2

01/05/2020 Avatar Therapy for people with schizophrenia or related disorders PMID:32413166.0 https://doi.org/10.1002/14651858.CD011898.pub2

01/08/2019 Acetylsalicylic acid (aspirin) for schizophrenia PMID:31425623.0 https://doi.org/10.1002/14651858.CD012116.pub2

01/08/2019 Benzodiazepines for catatonia in people with schizophrenia or other serious mental illnesses PMID:31425609.0 https://doi.org/10.1002/14651858.CD006570.pub3

01/04/2019 Peer support for people with schizophrenia or other serious mental illness PMID:30946482.0 https://doi.org/10.1002/14651858.CD010880.pub2

01/04/2019 Yoga as part of a package of care versus non-standard care for schizophrenia PMID:30990224.0 https://doi.org/10.1002/14651858.CD012807.pub2

01/04/2019 Haloperidol discontinuation for people with schizophrenia PMID:31006114.0 https://doi.org/10.1002/14651858.CD011408.pub2

01/03/2019 Electroconvulsive therapy for treatment-resistant schizophrenia PMID:30888709.0 https://doi.org/10.1002/14651858.CD011847.pub2

01/06/2018 Fluphenazine (oral) versus placebo for schizophrenia PMID:29893410.0 https://doi.org/10.1002/14651858.CD006352.pub3

01/05/2018 Increasing antipsychotic dose for non response in schizophrenia PMID:29750432.0 https://doi.org/10.1002/14651858.CD011883.pub2

01/05/2018 Mirtazapine adjunct for people with schizophrenia PMID:29802811.0 https://doi.org/10.1002/14651858.CD011943.pub2

01/05/2018 Increasing antipsychotic dose versus switching antipsychotic for non response in schizophrenia PMID:29749607.0 https://doi.org/10.1002/14651858.CD011884.pub2

01/04/2018 Gamma-aminobutyric acid agonists for antipsychotic-induced tardive dyskinesia PMID:29663328.0 https://doi.org/10.1002/14651858.CD000203.pub4

01/04/2018 Risperidone for psychosis-induced aggression or agitation (rapid tranquillisation) PMID:29634083.0 https://doi.org/10.1002/14651858.CD009412.pub2

01/03/2018 Cholinergic medication for antipsychotic-induced tardive dyskinesia PMID:29553158.0 https://doi.org/10.1002/14651858.CD000207.pub2

01/03/2018 Miscellaneous treatments for antipsychotic-induced tardive dyskinesia PMID:29552749.0 https://doi.org/10.1002/14651858.CD000208.pub2

01/03/2018 Calcium channel blockers for antipsychotic-induced tardive dyskinesia PMID:29578611.0 https://doi.org/10.1002/14651858.CD000206.pub4

01/02/2018 Antipsychotic reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia PMID:29409162.0 https://doi.org/10.1002/14651858.CD000459.pub3

01/01/2018 Benzodiazepines for antipsychotic-induced tardive dyskinesia PMID:29352477.0 https://doi.org/10.1002/14651858.CD000205.pub3

01/01/2018 Anticholinergic medication for antipsychotic-induced tardive dyskinesia PMID:29341071.0 https://doi.org/10.1002/14651858.CD000204.pub2

01/01/2018 Risperidone versus other antipsychotics for people with severe mental illness and co-occurring substance misuse PMID:29355909.0 https://doi.org/10.1002/14651858.CD011057.pub2

01/01/2018 Vitamin E for antipsychotic-induced tardive dyskinesia PMID:29341067.0 https://doi.org/10.1002/14651858.CD000209.pub3

01/01/2018 Aripiprazole (intramuscular) for psychosis-induced aggression or agitation (rapid tranquillisation) PMID:29308601.0 https://doi.org/10.1002/14651858.CD008074.pub2

01/01/2018 Non-antipsychotic catecholaminergic drugs for antipsychotic-induced tardive dyskinesia PMID:29342497.0 https://doi.org/10.1002/14651858.CD000458.pub3

01/09/2017 Yoga as part of a package of care versus standard care for schizophrenia PMID:28960019.0 https://doi.org/10.1002/14651858.CD012145.pub2

01/09/2017 Chlorpromazine versus penfluridol for schizophrenia PMID:28940256.0 https://doi.org/10.1002/14651858.CD011831.pub2

01/09/2017 Yoga versus non-standard care for schizophrenia PMID:28956893.0 https://doi.org/10.1002/14651858.CD012052.pub2

01/07/2017 Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation) PMID:28758203.0 https://doi.org/10.1002/14651858.CD009377.pub3

01/06/2017 Clozapine dose for schizophrenia PMID:28613395.0 https://doi.org/10.1002/14651858.CD009555.pub2

01/06/2017 Wendan decoction (Traditional Chinese medicine) for schizophrenia PMID:28657646.0 https://doi.org/10.1002/14651858.CD012217.pub2

01/06/2017 Communication skills training for mental health professionals working with people with severe mental illness PMID:28613384.0 https://doi.org/10.1002/14651858.CD010006.pub2

01/06/2017 Antipsychotic combinations for schizophrenia PMID:28658515.0 https://doi.org/10.1002/14651858.CD009005.pub2

01/05/2017 Music therapy for people with schizophrenia and schizophrenia-like disorders PMID:28553702.0 https://doi.org/10.1002/14651858.CD004025.pub4

01/04/2017 De-escalation techniques for psychosis-induced aggression or agitation PMID:28368091.0 https://doi.org/10.1002/14651858.CD009922.pub2

01/04/2017 Chlorpromazine versus clotiapine for schizophrenia PMID:28387925.0 https://doi.org/10.1002/14651858.CD011810.pub2

01/04/2017 Chlorpromazine dose for people with schizophrenia PMID:28407198.0 https://doi.org/10.1002/14651858.CD007778.pub2

01/03/2017 Chlorpromazine versus metiapine for schizophrenia PMID:28349512.0 https://doi.org/10.1002/14651858.CD011655.pub2

01/03/2017 Compulsory community and involuntary outpatient treatment for people with severe mental disorders PMID:28303578.0 https://doi.org/10.1002/14651858.CD004408.pub5

01/03/2017 Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia PMID:28333365.0 https://doi.org/10.1002/14651858.CD006324.pub3

01/01/2017 Intensive case management for severe mental illness PMID:28067944.0 https://doi.org/10.1002/14651858.CD007906.pub3

01/01/2017 Pharmacological treatment for antipsychotic-related constipation PMID:28116777.0 https://doi.org/10.1002/14651858.CD011128.pub2

01/01/2017 Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness PMID:28116752.0 https://doi.org/10.1002/14651858.CD011464.pub2

01/09/2016 HIV prevention advice for people with serious mental illness PMID:27609030.0 https://doi.org/10.1002/14651858.CD009639.pub3

01/09/2016 Oral health education (advice and training) for people with serious mental illness PMID:27606629.0 https://doi.org/10.1002/14651858.CD008802.pub3

01/09/2016 Interventions to encourage uptake of cancer screening for people with severe mental illness PMID:27668891.0 https://doi.org/10.1002/14651858.CD009641.pub3

01/07/2016 Fluphenazine (oral) versus atypical antipsychotics for schizophrenia PMID:27370402.0 https://doi.org/10.1002/14651858.CD010832.pub2

01/06/2016 Pharmacological interventions for clozapine-induced sinus tachycardia PMID:27277334.0 https://doi.org/10.1002/14651858.CD011566.pub2

01/04/2016 Chlorpromazine versus reserpine for schizophrenia PMID:27124109.0 https://doi.org/10.1002/14651858.CD012122.pub2

01/04/2016 Risperidone (depot) for schizophrenia PMID:27078222.0 https://doi.org/10.1002/14651858.CD004161.pub2

01/04/2016 Chlorpromazine versus atypical antipsychotic drugs for schizophrenia PMID:27045703.0 https://doi.org/10.1002/14651858.CD010631.pub2

01/03/2016 Dietary advice for people with schizophrenia PMID:27007216.0 https://doi.org/10.1002/14651858.CD009547.pub2

01/02/2016 Antioxidant treatments for schizophrenia PMID:26848926.0 https://doi.org/10.1002/14651858.CD008919.pub2

01/01/2016 Smoking cessation advice for people with serious mental illness PMID:26816385.0 https://doi.org/10.1002/14651858.CD009704.pub2

01/01/2016 Antiglucocorticoid and related treatments for psychosis PMID:26725721.0 https://doi.org/10.1002/14651858.CD006995.pub2

01/08/2015 Transcranial magnetic stimulation (TMS) for schizophrenia PMID:26289586.0 https://doi.org/10.1002/14651858.CD006081.pub2

01/08/2015 Voxel-based morphometry for separation of schizophrenia from other types of psychosis in first episode psychosis PMID:26252640.0 https://doi.org/10.1002/14651858.CD011021.pub2

01/06/2015 Social skills programmes for schizophrenia PMID:26059249.0 https://doi.org/10.1002/14651858.CD009006.pub2

01/05/2015 Psychoeducation for siblings of people with severe mental illness PMID:25953641.0 https://doi.org/10.1002/14651858.CD010540.pub2

01/05/2015 Treatments for delusional disorder PMID:25997589.0 https://doi.org/10.1002/14651858.CD009785.pub2

01/04/2015 Supportive therapy for schizophrenia PMID:25871462.0 https://doi.org/10.1002/14651858.CD004716.pub4

01/04/2015 Psychoeducation (brief) for people with serious mental illness PMID:25854522.0 https://doi.org/10.1002/14651858.CD010823.pub2

01/04/2015 Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesia PMID:25866243.0 https://doi.org/10.1002/14651858.CD010501.pub2

01/03/2015 Perphenazine for schizophrenia PMID:25749632.0 https://doi.org/10.1002/14651858.CD003443.pub3

01/02/2015 Fluphenazine decanoate (depot) and enanthate for schizophrenia PMID:25654768.0 https://doi.org/10.1002/14651858.CD000307.pub2

01/01/2015 Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders PMID:25592299.0 https://doi.org/10.1002/14651858.CD009831.pub2

01/01/2015 First rank symptoms for schizophrenia PMID:25879096.0 https://doi.org/10.1002/14651858.CD010653.pub2

01/09/2014 Flupenthixol versus low-potency first-generation antipsychotic drugs for schizophrenia PMID:25177834.0 https://doi.org/10.1002/14651858.CD009227.pub2

01/08/2014 Fluphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia PMID:25087165.0 https://doi.org/10.1002/14651858.CD009230.pub2

01/07/2014 Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia PMID:25007358.0 https://doi.org/10.1002/14651858.CD009268.pub2

01/06/2014 Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders PMID:24915451.0 https://doi.org/10.1002/14651858.CD001470.pub2

01/06/2014 Information and communication technology based prompting for treatment compliance for people with serious mental illness PMID:24934254.0 https://doi.org/10.1002/14651858.CD009960.pub2

01/05/2014 Horticultural therapy for schizophrenia PMID:24842458.0 https://doi.org/10.1002/14651858.CD009413.pub2

01/05/2014 Carbamazepine for schizophrenia PMID:24789267.0 https://doi.org/10.1002/14651858.CD001258.pub3

01/05/2014 Pericyazine for schizophrenia PMID:24825770.0 https://doi.org/10.1002/14651858.CD007479.pub2

01/04/2014 Sulpiride versus placebo for schizophrenia PMID:24729184.0 https://doi.org/10.1002/14651858.CD007811.pub2

01/03/2014 General physical health advice for people with serious mental illness PMID:24676557.0 https://doi.org/10.1002/14651858.CD008567.pub3

01/03/2014 Family intervention (brief) for schizophrenia PMID:24595545.0 https://doi.org/10.1002/14651858.CD009802.pub2

01/01/2014 Aripiprazole versus other atypical antipsychotics for schizophrenia PMID:24385408.0 https://doi.org/10.1002/14651858.CD006569.pub5

01/01/2014 Physical health care monitoring for people with serious mental illness PMID:24442580.0 https://doi.org/10.1002/14651858.CD008298.pub3

01/01/2014 Perazine for schizophrenia PMID:24425538.0 https://doi.org/10.1002/14651858.CD002832.pub3

01/01/2014 Chlorpromazine versus placebo for schizophrenia PMID:24395698.0 https://doi.org/10.1002/14651858.CD000284.pub3

01/01/2014 Length of hospitalisation for people with severe mental illness PMID:24477710.0 https://doi.org/10.1002/14651858.CD000384.pub3

01/09/2013 Supported employment for adults with severe mental illness PMID:24030739.0 https://doi.org/10.1002/14651858.CD008297.pub2

01/08/2013 Haloperidol dose for the acute phase of schizophrenia PMID:23983042.0 https://doi.org/10.1002/14651858.CD001951.pub2

01/07/2013 Intermittent drug techniques for schizophrenia PMID:23881657.0 https://doi.org/10.1002/14651858.CD006196.pub2

01/06/2013 Preventive interventions for postnatal psychosis PMID:23740790.0 https://doi.org/10.1002/14651858.CD009991.pub2

01/05/2013 Quetiapine versus typical antipsychotic medications for schizophrenia PMID:23728667.0 https://doi.org/10.1002/14651858.CD007815.pub2

01/03/2013 Nidotherapy for people with schizophrenia PMID:23543583.0 https://doi.org/10.1002/14651858.CD009929.pub2

01/02/2013 Training to recognise the early signs of recurrence in schizophrenia PMID:23450559.0 https://doi.org/10.1002/14651858.CD005147.pub2

01/06/2012 Paliperidone palmitate for schizophrenia PMID:22696377.0 https://doi.org/10.1002/14651858.CD008296.pub2

01/04/2012 Zuclopenthixol acetate for acute schizophrenia and similar serious mental illnesses PMID:22513898.0 https://doi.org/10.1002/14651858.CD000525.pub3

01/02/2012 Antipsychotic drug treatment for elderly people with late-onset schizophrenia PMID:22336800.0 https://doi.org/10.1002/14651858.CD004162.pub2

01/01/2012 Life skills programmes for chronic mental illnesses PMID:22258941.0 https://doi.org/10.1002/14651858.CD000381.pub3

01/08/2011 Aripiprazole versus placebo for schizophrenia PMID:21833956.0 https://doi.org/10.1002/14651858.CD006622.pub2

01/06/2011 Psychoeducation for schizophrenia PMID:21678337.0 https://doi.org/10.1002/14651858.CD002831.pub2

01/06/2011 Early intervention for psychosis PMID:21678345.0 https://doi.org/10.1002/14651858.CD004718.pub3

01/06/2011 Antipsychotic medication for early episode schizophrenia PMID:21678355.0 https://doi.org/10.1002/14651858.CD006374.pub2

01/12/2018 Cognitive behavioural therapy plus standard care versus standard care for people with schizophrenia PMID:30572373.0 https://doi.org/10.1002/14651858.CD007964.pub2

01/11/2019 Interventions for prodromal stage of psychosis PMID:31689359.0 https://doi.org/10.1002/14651858.CD012236.pub2

01/12/2019 Psychosocial interventions for people with both severe mental illness and substance misuse PMID:31829430.0 https://doi.org/10.1002/14651858.CD001088.pub4

01/12/2019 Treatments for primary delusional infestation PMID:31821546.0 https://doi.org/10.1002/14651858.CD011326.pub2

01/12/2019 Modafinil for people with schizophrenia or related disorders PMID:31828767.0 https://doi.org/10.1002/14651858.CD008661.pub2